https://www.spreaker.com/podcast/radonc-smart-review--6594670enEducationCopyright radoncsmartlearnhttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/1db0bdc4b5d27f9c2aba928561feeaf2.jpghttps://www.spreaker.com/podcast/radonc-smart-review--6594670Sat, 29 Aug 2026 23:23:34 +0000Abass Contehradoncsmartlearnsupport@radoncsmartlearn.comAI Generated Podcast reviewing various topics in Radiation Oncology for Residents on the go.false576d8359-08d3-5459-bf4a-e471e2b6a5a2episodichttps://www.spreaker.com/episode/g-i-e03-resectable-esophageal-and-gej-cancer-cross-flot-and-perioperative-selection--74750485ffb1bc70-05c4-4cd8-bc90-ffc9dc2ae765Sat, 29 Aug 2026 21:45:02 +0000Abass ContehEpisode 3: Resectable Esophageal and GEJ Cancer: CROSS, FLOT, and Perioperative Selection. The modern approach to resectable esophageal cancer has evolved beyond simply asking if a patient needs preoperative treatment; for most locally advanced...1525falsefullhttps://www.spreaker.com/episode/g-i-e02-esophageal-and-gej-cancer-anatomy-workup-staging-and-surgery--7475048493018102-1484-4b6b-b557-c55997a88d3dSat, 29 Aug 2026 21:08:21 +0000Abass ContehEpisode 2: Esophageal and GEJ Cancer Anatomy, Workup, Staging, and Surgery. In this episode, we explore how esophageal cancer punishes imprecise anatomy. We discuss why a difference of just a few centimeters can fundamentally alter the primary site,...1414falsefullhttps://www.spreaker.com/episode/g-i-e01-foundations-workup-intent-planning-safety-and-cross-cutting-toxicity--746181944bac0871-62be-416d-8c52-427c51fca02aMon, 24 Aug 2026 03:20:38 +0000Abass ContehThis is Episode one: G I Oncology Foundations, Workup, Intent, Planning Safety, and Cross Cutting Toxicity.The most dangerous G I oncology error is often not choosing the wrong dose. It is answering the dose question before proving the diagnosis,...1289falsefullhttps://www.spreaker.com/episode/thoracic-e30-comprehensive-thoracic-mock-oral-review--73368267Episode 30 is the comprehensive Thoracic mock oral. Three case blocks cover metastatic disease with consolidation versus oligoprogression, superior vena cava syndrome and thymic carcinoma, and a post-treatment pulmonary syndrome followed by thoracic reirradiation decisions. Each case includes a contrasting twist that changes the recommendation.
Pause before every model answer. Lead with the diagnosis or differential, known extent, and immediate problem; state intent before technique; name the management-changing unknown; and carry the plan through sequencing, radiation details, toxicity, surveillance, salvage, and the point at which the treatment goal must change.]]>49c968d5-ce2c-4f1a-ab5a-9284f923f82fMon, 03 Aug 2026 03:31:21 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 30 is the comprehensive Thoracic mock oral. Three case blocks cover metastatic disease with consolidation versus oligoprogression, superior vena cava syndrome and thymic...Episode 30 is the comprehensive Thoracic mock oral. Three case blocks cover metastatic disease with consolidation versus oligoprogression, superior vena cava syndrome and thymic carcinoma, and a post-treatment pulmonary syndrome followed by thoracic reirradiation decisions. Each case includes a contrasting twist that changes the recommendation.
Pause before every model answer. Lead with the diagnosis or differential, known extent, and immediate problem; state intent before technique; name the management-changing unknown; and carry the plan through sequencing, radiation details, toxicity, surveillance, salvage, and the point at which the treatment goal must change.]]>2084false30fullhttps://www.spreaker.com/episode/thoracic-e29-thoracic-oncology-board-synthesis--73368272Episode 29 is a board-synthesis workshop built around the order of operations that keeps thoracic decisions safe. We move from diagnosis and stage uncertainty to management-changing workup, invasive staging, operability, resectability, treatment intent, multimodality sequence, radiation indication, planning priorities, toxicity, surveillance, and salvage.
The disease-specific path changes across non-small cell lung cancer, small cell lung cancer, thymic tumors, mesothelioma, metastatic disease, palliation, toxicity, and reirradiation—but the decision discipline should remain portable.]]>61574c32-2894-4f41-aac9-c6e00895905cMon, 03 Aug 2026 03:30:30 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 29 is a board-synthesis workshop built around the order of operations that keeps thoracic decisions safe. We move from diagnosis and stage uncertainty to management-changing...Episode 29 is a board-synthesis workshop built around the order of operations that keeps thoracic decisions safe. We move from diagnosis and stage uncertainty to management-changing workup, invasive staging, operability, resectability, treatment intent, multimodality sequence, radiation indication, planning priorities, toxicity, surveillance, and salvage.
The disease-specific path changes across non-small cell lung cancer, small cell lung cancer, thymic tumors, mesothelioma, metastatic disease, palliation, toxicity, and reirradiation—but the decision discipline should remain portable.]]>2501false29fullhttps://www.spreaker.com/episode/thoracic-e28-thoracic-reirradiation-and-cumulative-dose--73368277Episode 28 approaches thoracic reirradiation as a new treatment decision made in the shadow of a prior course. Before discussing dose, we define intent, alternatives, expected benefit, prior-plan reconstruction, registration uncertainty, cumulative exposure, and the organ that could turn an elegant plan into a catastrophic event.
The episode provides a framework for balancing meaningful local control against potentially irreversible or fatal toxicity, communicating uncertainty honestly, and recognizing when cumulative central-organ risk makes another strategy safer.]]>d1b9fe1a-5001-4d13-8db4-f3b1f8bedc1eMon, 03 Aug 2026 03:29:36 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 28 approaches thoracic reirradiation as a new treatment decision made in the shadow of a prior course. Before discussing dose, we define intent, alternatives, expected benefit,...Episode 28 approaches thoracic reirradiation as a new treatment decision made in the shadow of a prior course. Before discussing dose, we define intent, alternatives, expected benefit, prior-plan reconstruction, registration uncertainty, cumulative exposure, and the organ that could turn an elegant plan into a catastrophic event.
The episode provides a framework for balancing meaningful local control against potentially irreversible or fatal toxicity, communicating uncertainty honestly, and recognizing when cumulative central-organ risk makes another strategy safer.]]>2736false28fullhttps://www.spreaker.com/episode/thoracic-e27-thoracic-toxicity-prevention-recognition-and-differential-diagnosis--73368286Episode 27 tackles thoracic toxicity as a differential-diagnosis problem. Cough, dyspnea, dysphagia, fever, fatigue, chest discomfort, and palpitations may reflect radiation injury, infection, recurrent cancer, airway obstruction, cardiac disease, dehydration, systemic therapy, or more than one process at once.
Using a post-chemoradiation patient with evolving pulmonary and swallowing symptoms, we practice stability assessment, severity grading, treatment reconstruction, comparison with delivered dose, testing of dangerous alternatives, interruption and escalation decisions, and documentation of uncertainty with a clear reassessment endpoint.]]>71042038-4e4a-4cf7-a7e3-21bf44bf91d3Mon, 03 Aug 2026 03:28:27 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 27 tackles thoracic toxicity as a differential-diagnosis problem. Cough, dyspnea, dysphagia, fever, fatigue, chest discomfort, and palpitations may reflect radiation injury,...Episode 27 tackles thoracic toxicity as a differential-diagnosis problem. Cough, dyspnea, dysphagia, fever, fatigue, chest discomfort, and palpitations may reflect radiation injury, infection, recurrent cancer, airway obstruction, cardiac disease, dehydration, systemic therapy, or more than one process at once.
Using a post-chemoradiation patient with evolving pulmonary and swallowing symptoms, we practice stability assessment, severity grading, treatment reconstruction, comparison with delivered dose, testing of dangerous alternatives, interruption and escalation decisions, and documentation of uncertainty with a clear reassessment endpoint.]]>2186false27fullhttps://www.spreaker.com/episode/thoracic-e26-pleural-mesothelioma--73368273Episode 26 treats pleural mesothelioma as the surface-spreading disease it is—not as a spherical lung mass. We cover diagnostic adequacy, histology, anatomic extent, operability, and whether meaningful cytoreduction is achievable before turning to the radiation problem.
Planning then branches by operation. After lung-sparing pleurectomy and decortication, two lungs remain around a large concave pleural target; after extrapleural pneumonectomy, one lung remains and even a modest low-dose bath can be dangerous. The recommendation must begin with the actual operation and expected pulmonary risk.]]>560a7518-183e-4114-8a6d-340ffeee3b51Mon, 03 Aug 2026 03:27:31 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 26 treats pleural mesothelioma as the surface-spreading disease it is—not as a spherical lung mass. We cover diagnostic adequacy, histology, anatomic extent, operability, and...Episode 26 treats pleural mesothelioma as the surface-spreading disease it is—not as a spherical lung mass. We cover diagnostic adequacy, histology, anatomic extent, operability, and whether meaningful cytoreduction is achievable before turning to the radiation problem.
Planning then branches by operation. After lung-sparing pleurectomy and decortication, two lungs remain around a large concave pleural target; after extrapleural pneumonectomy, one lung remains and even a modest low-dose bath can be dangerous. The recommendation must begin with the actual operation and expected pulmonary risk.]]>2574false26fullhttps://www.spreaker.com/episode/thoracic-e25-thymic-malignancies-and-selected-rare-thoracic-tumors--73368278Episode 25 uses thymic malignancies to build a disciplined approach to rare thoracic tumors. We address diagnostic pathways, myasthenic symptoms, biopsy-route hazards, the difference between operability and an R0 resection, true invasion versus simple contact, postoperative radiation selection, and reconstruction of the tumor bed.
The larger lesson is how to reason when evidence is sparse: avoid automatic extrapolation from common lung cancer, state uncertainty honestly, and build a recommendation from anatomy, pathology, surgical findings, recurrence risk, and achievable treatment geometry.]]>9f75adc3-315a-4cf2-b99e-0087448e6a74Mon, 03 Aug 2026 03:26:36 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 25 uses thymic malignancies to build a disciplined approach to rare thoracic tumors. We address diagnostic pathways, myasthenic symptoms, biopsy-route hazards, the difference...Episode 25 uses thymic malignancies to build a disciplined approach to rare thoracic tumors. We address diagnostic pathways, myasthenic symptoms, biopsy-route hazards, the difference between operability and an R0 resection, true invasion versus simple contact, postoperative radiation selection, and reconstruction of the tumor bed.
The larger lesson is how to reason when evidence is sparse: avoid automatic extrapolation from common lung cancer, state uncertainty honestly, and build a recommendation from anatomy, pathology, surgical findings, recurrence risk, and achievable treatment geometry.]]>2213false25fullhttps://www.spreaker.com/episode/thoracic-e24-thoracic-palliation-and-oncologic-emergencies--73368284Episode 24 brings structure to thoracic palliation and oncologic emergencies. We balance the danger of moving too slowly during airway, vascular, spinal-cord, pericardial, or respiratory compromise against the harm of giving empiric radiation to a stable patient before preserving diagnosis, stage, and the best procedural or systemic option.
The episode emphasizes stabilization first, then intervention matched to mechanism and time horizon. Radiation may be central, adjunctive, delayed until tissue is obtained, or unnecessary when another treatment is more direct.]]>7255eff3-8eb9-4923-bcbc-f4e84819c310Mon, 03 Aug 2026 03:25:47 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 24 brings structure to thoracic palliation and oncologic emergencies. We balance the danger of moving too slowly during airway, vascular, spinal-cord, pericardial, or respiratory...Episode 24 brings structure to thoracic palliation and oncologic emergencies. We balance the danger of moving too slowly during airway, vascular, spinal-cord, pericardial, or respiratory compromise against the harm of giving empiric radiation to a stable patient before preserving diagnosis, stage, and the best procedural or systemic option.
The episode emphasizes stabilization first, then intervention matched to mechanism and time horizon. Radiation may be central, adjunctive, delayed until tissue is obtained, or unnecessary when another treatment is more direct.]]>2517false24fullhttps://www.spreaker.com/episode/thoracic-e23-oligometastatic-and-oligoprogressive-non-small-cell-lung-cancer--73366167Episode 23 separates two often-confused strategies in limited metastatic non-small cell lung cancer: comprehensive treatment of every known site after systemic control and ablation of a resistant site during otherwise effective therapy. A lesion count alone is not a biological diagnosis or a treatment indication.
Using a thoracic primary with limited adrenal and bone disease as the anchor, we examine diagnostic confidence, systemic response, disease pace, technical feasibility, cumulative toxicity, and whether local therapy truly complements the systemic strategy rather than delaying recognition of widespread failure.]]>d13a939e-50d2-4343-94f8-f6974791a514Mon, 03 Aug 2026 03:21:26 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 23 separates two often-confused strategies in limited metastatic non-small cell lung cancer: comprehensive treatment of every known site after systemic control and ablation of a...Episode 23 separates two often-confused strategies in limited metastatic non-small cell lung cancer: comprehensive treatment of every known site after systemic control and ablation of a resistant site during otherwise effective therapy. A lesion count alone is not a biological diagnosis or a treatment indication.
Using a thoracic primary with limited adrenal and bone disease as the anchor, we examine diagnostic confidence, systemic response, disease pace, technical feasibility, cumulative toxicity, and whether local therapy truly complements the systemic strategy rather than delaying recognition of widespread failure.]]>2224false23fullhttps://www.spreaker.com/episode/thoracic-e22-metastatic-non-small-cell-lung-cancer-and-radiation-therapy-systemic-therapy-integration--73366166Episode 22 focuses on integrating radiation and systemic therapy in metastatic non-small cell lung cancer without allowing two independent treatment calendars to collide. The durable skill is not memorizing one universal drug-hold table, but making a transparent risk decision for the exact agent, target, dose per fraction, organ exposure, urgency, and prior toxicity.
We also define ownership: who pauses treatment, what evidence is required to restart, and how to balance radiation benefit against the consequences of interrupting an effective systemic therapy.]]>8c6ca9c6-a79c-49f5-9c00-53b46f3dee1bMon, 03 Aug 2026 03:20:27 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 22 focuses on integrating radiation and systemic therapy in metastatic non-small cell lung cancer without allowing two independent treatment calendars to collide. The durable...Episode 22 focuses on integrating radiation and systemic therapy in metastatic non-small cell lung cancer without allowing two independent treatment calendars to collide. The durable skill is not memorizing one universal drug-hold table, but making a transparent risk decision for the exact agent, target, dose per fraction, organ exposure, urgency, and prior toxicity.
We also define ownership: who pauses treatment, what evidence is required to restart, and how to balance radiation benefit against the consequences of interrupting an effective systemic therapy.]]>1854false22fullhttps://www.spreaker.com/episode/thoracic-e21-stage-iii-non-small-cell-lung-cancer-and-small-cell-lung-cancer-mock-oral--73366190Episode 21 is a three-block mock oral covering fit unresectable stage III non-small cell lung cancer, frail unresectable stage III disease, and small cell lung cancer. The cases test concurrent versus modified chemoradiation, planning and toxicity management, post-treatment selection, brain-directed decisions, surveillance, and salvage.
Pause before each answer. Lead with diagnosis, stage framework, and intent; identify the stage-driving evidence; distinguish operability from resectability; then defend the treatment sequence, radiation plan, organ-at-risk tradeoffs, interruption strategy, and the finding that would change your recommendation.]]>f8422489-6fe7-4690-a487-6f5bfe8c7548Mon, 03 Aug 2026 03:19:30 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 21 is a three-block mock oral covering fit unresectable stage III non-small cell lung cancer, frail unresectable stage III disease, and small cell lung cancer. The cases test...Episode 21 is a three-block mock oral covering fit unresectable stage III non-small cell lung cancer, frail unresectable stage III disease, and small cell lung cancer. The cases test concurrent versus modified chemoradiation, planning and toxicity management, post-treatment selection, brain-directed decisions, surveillance, and salvage.
Pause before each answer. Lead with diagnosis, stage framework, and intent; identify the stage-driving evidence; distinguish operability from resectability; then defend the treatment sequence, radiation plan, organ-at-risk tradeoffs, interruption strategy, and the finding that would change your recommendation.]]>2624false21fullhttps://www.spreaker.com/episode/thoracic-e20-extensive-stage-small-cell-lung-cancer-and-thoracic-radiation--73366183Episode 20 clarifies the selective role of thoracic radiation in extensive-stage small cell lung cancer. We distinguish consolidative treatment after a favorable systemic response from palliative treatment for symptoms or threatened thoracic function—two indications that may use the same machine but differ in intent, urgency, target, dose, and acceptable burden.
Using persistent thoracic disease after systemic therapy as the anchor, we weigh extracranial disease pace, functional trajectory, competing systemic risk, symptom risk, and whether a meaningful thoracic target can be treated safely.]]>d68c5b4c-9459-43d1-890d-c0e29a214056Mon, 03 Aug 2026 03:18:38 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 20 clarifies the selective role of thoracic radiation in extensive-stage small cell lung cancer. We distinguish consolidative treatment after a favorable systemic response from...Episode 20 clarifies the selective role of thoracic radiation in extensive-stage small cell lung cancer. We distinguish consolidative treatment after a favorable systemic response from palliative treatment for symptoms or threatened thoracic function—two indications that may use the same machine but differ in intent, urgency, target, dose, and acceptable burden.
Using persistent thoracic disease after systemic therapy as the anchor, we weigh extracranial disease pace, functional trajectory, competing systemic risk, symptom risk, and whether a meaningful thoracic target can be treated safely.]]>1982false20fullhttps://www.spreaker.com/episode/thoracic-e19-pci-mri-surveillance-and-hippocampal-avoidance--73366193Episode 19 examines the decision between prophylactic cranial irradiation and structured MRI surveillance in small cell lung cancer, including the role of hippocampal avoidance. We place the evidence in its imaging and treatment era rather than treating older trials as if every patient had modern brain MRI and dependable salvage access.
The discussion centers on shared decision-making: intracranial-control benefit, disease extent and response, surveillance reliability, neurocognitive risk, functional priorities, and the practical consequences of choosing observation or cranial treatment.]]>324a8c89-6a45-4d5d-95ef-d9b70f3c2e46Mon, 03 Aug 2026 03:17:36 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 19 examines the decision between prophylactic cranial irradiation and structured MRI surveillance in small cell lung cancer, including the role of hippocampal avoidance. We place...Episode 19 examines the decision between prophylactic cranial irradiation and structured MRI surveillance in small cell lung cancer, including the role of hippocampal avoidance. We place the evidence in its imaging and treatment era rather than treating older trials as if every patient had modern brain MRI and dependable salvage access.
The discussion centers on shared decision-making: intracranial-control benefit, disease extent and response, surveillance reliability, neurocognitive risk, functional priorities, and the practical consequences of choosing observation or cranial treatment.]]>2601false19fullhttps://www.spreaker.com/episode/thoracic-e18-limited-stage-small-cell-lung-cancer-timing-planning-and-consolidation--73366182Episode 18 follows limited-stage small cell lung cancer from the start of chemotherapy through thoracic radiation planning and post-treatment decisions. We discuss treatment timing, fractionation, target construction, the use of pre- and post-chemotherapy disease information, image guidance, and how toxicity or interruptions change the plan.
The episode keeps the sequence coherent: choose a curative strategy the patient can complete, avoid losing clinically meaningful disease in the planning process, and reassess response before decisions about consolidation and brain-directed management.]]>c01cc29f-9b17-48ae-9e8c-40cf1cee54d0Mon, 03 Aug 2026 03:16:30 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 18 follows limited-stage small cell lung cancer from the start of chemotherapy through thoracic radiation planning and post-treatment decisions. We discuss treatment timing,...Episode 18 follows limited-stage small cell lung cancer from the start of chemotherapy through thoracic radiation planning and post-treatment decisions. We discuss treatment timing, fractionation, target construction, the use of pre- and post-chemotherapy disease information, image guidance, and how toxicity or interruptions change the plan.
The episode keeps the sequence coherent: choose a curative strategy the patient can complete, avoid losing clinically meaningful disease in the planning process, and reassess response before decisions about consolidation and brain-directed management.]]>2593false18fullhttps://www.spreaker.com/episode/thoracic-e17-sclc-foundations-and-curative-treatment--73366220Episode 17 establishes the foundations of small cell lung cancer care: pathologic confirmation, complete staging, mandatory attention to brain imaging, the rare role of surgery, and entry into curative treatment for limited-stage disease.
We focus on the decisions that prevent stage and intent errors—distinguishing limited from extensive disease, identifying when invasive staging or additional workup matters, and coordinating chemotherapy with thoracic radiation. The goal is a concise, board-ready framework that remains accurate when the clinical presentation is incomplete.]]>8c932bc6-6146-41c9-8d74-cb3d1259cb3dMon, 03 Aug 2026 03:15:25 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 17 establishes the foundations of small cell lung cancer care: pathologic confirmation, complete staging, mandatory attention to brain imaging, the rare role of surgery, and...Episode 17 establishes the foundations of small cell lung cancer care: pathologic confirmation, complete staging, mandatory attention to brain imaging, the rare role of surgery, and entry into curative treatment for limited-stage disease.
We focus on the decisions that prevent stage and intent errors—distinguishing limited from extensive disease, identifying when invasive staging or additional workup matters, and coordinating chemotherapy with thoracic radiation. The goal is a concise, board-ready framework that remains accurate when the clinical presentation is incomplete.]]>2695false17fullhttps://www.spreaker.com/episode/thoracic-e16-after-definitive-crt-consolidation-toxicity-and-relapse--73366231Episode 16 begins where definitive chemoradiation ends. We organize post-treatment care around three competing possibilities: eligibility for consolidation therapy, clinically important toxicity, and early relapse or progression.
The episode shows how to interpret symptoms and imaging without prematurely labeling every pulmonary change as radiation injury, how to stabilize and evaluate treatment-limiting toxicity, and how molecular findings, performance status, disease distribution, and prior therapy shape the next systemic or local treatment decision.]]>1ac10293-97e2-4268-9101-3aac3b056942Mon, 03 Aug 2026 03:14:13 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 16 begins where definitive chemoradiation ends. We organize post-treatment care around three competing possibilities: eligibility for consolidation therapy, clinically important...Episode 16 begins where definitive chemoradiation ends. We organize post-treatment care around three competing possibilities: eligibility for consolidation therapy, clinically important toxicity, and early relapse or progression.
The episode shows how to interpret symptoms and imaging without prematurely labeling every pulmonary change as radiation injury, how to stabilize and evaluate treatment-limiting toxicity, and how molecular findings, performance status, disease distribution, and prior therapy shape the next systemic or local treatment decision.]]>2650false16fullhttps://www.spreaker.com/episode/thoracic-e15-stage-three-targeting-and-treatment-planning--73366216Episode 15 is a planning-focused guide to definitive radiation for stage III non-small cell lung cancer. We move from simulation and motion assessment to gross disease, nodal volumes, target margins, technique, image guidance, adaptive triggers, and plan appraisal.
The core challenge is not simply achieving coverage. It is building a defensible plan that reflects the actual disease map while controlling heart, lung, esophageal, spinal-cord, and treatment-time risks. We also discuss when anatomy or response has changed enough that the original plan should no longer be treated as valid.]]>63a3f914-1715-4f1f-bc49-d87489b7fff4Mon, 03 Aug 2026 03:13:14 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 15 is a planning-focused guide to definitive radiation for stage III non-small cell lung cancer. We move from simulation and motion assessment to gross disease, nodal volumes,...Episode 15 is a planning-focused guide to definitive radiation for stage III non-small cell lung cancer. We move from simulation and motion assessment to gross disease, nodal volumes, target margins, technique, image guidance, adaptive triggers, and plan appraisal.
The core challenge is not simply achieving coverage. It is building a defensible plan that reflects the actual disease map while controlling heart, lung, esophageal, spinal-cord, and treatment-time risks. We also discuss when anatomy or response has changed enough that the original plan should no longer be treated as valid.]]>2292false15fullhttps://www.spreaker.com/episode/thoracic-e14-definitive-stage-three-management--73366172Episode 14 builds the definitive treatment framework for unresectable stage III non-small cell lung cancer. We begin by confirming a curable nonsurgical disease state, completing stage-defining workup, and deciding whether the patient can safely complete concurrent chemoradiation or needs a modified sequence.
From there, we connect treatment intensity to radiation dose, systemic therapy, interruption management, post-chemoradiation consolidation, surveillance, and relapse. The emphasis is on preserving curative intent when appropriate while making frailty, toxicity, progression, and molecular findings explicit decision points.]]>617a196d-e34a-422e-ac33-dd8fcc8d6e64Mon, 03 Aug 2026 03:11:47 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 14 builds the definitive treatment framework for unresectable stage III non-small cell lung cancer. We begin by confirming a curable nonsurgical disease state, completing...Episode 14 builds the definitive treatment framework for unresectable stage III non-small cell lung cancer. We begin by confirming a curable nonsurgical disease state, completing stage-defining workup, and deciding whether the patient can safely complete concurrent chemoradiation or needs a modified sequence.
From there, we connect treatment intensity to radiation dose, systemic therapy, interruption management, post-chemoradiation consolidation, surveillance, and relapse. The emphasis is on preserving curative intent when appropriate while making frailty, toxicity, progression, and molecular findings explicit decision points.]]>2688false14fullhttps://www.spreaker.com/episode/thoracic-e13-localized-and-resectable-non-small-cell-lung-cancer-mock-oral--73366171Episode 13 is a three-block mock oral in localized and resectable non-small cell lung cancer. The cases move from surgery versus stereotactic radiation for peripheral disease, to central and ultracentral anatomy, and then to resectable nodal and superior sulcus disease with multimodality sequencing and postoperative decisions.
Pause before each model answer and give a structured response: state the diagnosis and known extent, name the management-changing unknown, separate operability from resectability, declare treatment intent, and carry the recommendation through evidence, planning, safety, surveillance, and salvage.]]>2b016b3e-8bef-4b41-ad98-d24027c31121Mon, 03 Aug 2026 03:10:32 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 13 is a three-block mock oral in localized and resectable non-small cell lung cancer. The cases move from surgery versus stereotactic radiation for peripheral disease, to central...Episode 13 is a three-block mock oral in localized and resectable non-small cell lung cancer. The cases move from surgery versus stereotactic radiation for peripheral disease, to central and ultracentral anatomy, and then to resectable nodal and superior sulcus disease with multimodality sequencing and postoperative decisions.
Pause before each model answer and give a structured response: state the diagnosis and known extent, name the management-changing unknown, separate operability from resectability, declare treatment intent, and carry the recommendation through evidence, planning, safety, surveillance, and salvage.]]>2452false13fullhttps://www.spreaker.com/episode/thoracic-e12-port-evidence-selection-and-planning--73366236Episode 12 takes a selective, evidence-based approach to postoperative radiation therapy for non-small cell lung cancer. We reconstruct residual disease, margin status, nodal burden and geography, surgical quality, the preoperative disease map, competing systemic risk, cardiopulmonary reserve, and the target that would actually be treated.
The episode explains why improved mediastinal control after complete resection does not automatically translate into a survival benefit, and how to weigh that local-control gain against heart, remaining-lung, esophageal, and spinal-cord exposure.]]>a5237633-eb54-4f13-adae-138e73e8095eMon, 03 Aug 2026 03:09:41 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 12 takes a selective, evidence-based approach to postoperative radiation therapy for non-small cell lung cancer. We reconstruct residual disease, margin status, nodal burden and...Episode 12 takes a selective, evidence-based approach to postoperative radiation therapy for non-small cell lung cancer. We reconstruct residual disease, margin status, nodal burden and geography, surgical quality, the preoperative disease map, competing systemic risk, cardiopulmonary reserve, and the target that would actually be treated.
The episode explains why improved mediastinal control after complete resection does not automatically translate into a survival benefit, and how to weigh that local-control gain against heart, remaining-lung, esophageal, and spinal-cord exposure.]]>2637false12fullhttps://www.spreaker.com/episode/thoracic-e11-trimodality-therapy-and-superior-sulcus-tumors--73366176Episode 11 examines trimodality therapy through the demanding example of a superior sulcus tumor. Before chemotherapy and radiation begin, the team must define thoracic-inlet invasion, nodal status, the feasibility of a margin-negative operation, the patient’s ability to tolerate that operation, and what the definitive fallback will be if surgery is cancelled.
We connect multidisciplinary selection to simulation, target design, organ-at-risk priorities, surgical timing, and continuity of curative treatment—so the sequence is a planned oncologic strategy rather than three disconnected modalities.]]>ea7f8402-e3f8-446c-9b29-e7103427f50bMon, 03 Aug 2026 03:08:50 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 11 examines trimodality therapy through the demanding example of a superior sulcus tumor. Before chemotherapy and radiation begin, the team must define thoracic-inlet invasion,...Episode 11 examines trimodality therapy through the demanding example of a superior sulcus tumor. Before chemotherapy and radiation begin, the team must define thoracic-inlet invasion, nodal status, the feasibility of a margin-negative operation, the patient’s ability to tolerate that operation, and what the definitive fallback will be if surgery is cancelled.
We connect multidisciplinary selection to simulation, target design, organ-at-risk priorities, surgical timing, and continuity of curative treatment—so the sequence is a planned oncologic strategy rather than three disconnected modalities.]]>1975false11fullhttps://www.spreaker.com/episode/thoracic-e10-resectable-stage-ii-through-iii-non-small-cell-lung-cancer--73366177Episode 10 builds a coherent curative strategy for resectable stage II through III non-small cell lung cancer. We show why a stage label alone cannot define medical operability, anatomic resectability, the required operation, the meaning of a PET-avid mediastinal node, or the best perioperative sequence.
The episode keeps radiation oncology engaged at the right moments: before a treatment path closes, when trimodality therapy is genuinely under consideration, and when response, margin status, residual nodal burden, or surgical findings reopen the local-risk calculation.]]>09db83f8-f36f-4f69-8020-c5d3c676f390Mon, 03 Aug 2026 03:08:06 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 10 builds a coherent curative strategy for resectable stage II through III non-small cell lung cancer. We show why a stage label alone cannot define medical operability, anatomic...Episode 10 builds a coherent curative strategy for resectable stage II through III non-small cell lung cancer. We show why a stage label alone cannot define medical operability, anatomic resectability, the required operation, the meaning of a PET-avid mediastinal node, or the best perioperative sequence.
The episode keeps radiation oncology engaged at the right moments: before a treatment path closes, when trimodality therapy is genuinely under consideration, and when response, margin status, residual nodal burden, or surgical findings reopen the local-risk calculation.]]>2424false10fullhttps://www.spreaker.com/episode/thoracic-e09-post-sbrt-imaging-recurrence-and-salvage--73366204Episode 9 addresses one of the hardest surveillance problems after lung stereotactic body radiation therapy: distinguishing expected evolving fibrosis and inflammation from true local recurrence. We integrate time from treatment, serial morphology, metabolic behavior, symptoms, physiology, original dose geometry, restaging, and the feasibility of biopsy.
The second half turns suspicion into a salvage decision. The goal is to preserve a potentially curative opportunity without treating benign post-treatment change or causing disproportionate injury to previously irradiated thoracic organs.]]>757f0afb-e03b-473d-b687-534fd2831b3bMon, 03 Aug 2026 03:06:20 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 9 addresses one of the hardest surveillance problems after lung stereotactic body radiation therapy: distinguishing expected evolving fibrosis and inflammation from true local...Episode 9 addresses one of the hardest surveillance problems after lung stereotactic body radiation therapy: distinguishing expected evolving fibrosis and inflammation from true local recurrence. We integrate time from treatment, serial morphology, metabolic behavior, symptoms, physiology, original dose geometry, restaging, and the feasibility of biopsy.
The second half turns suspicion into a salvage decision. The goal is to preserve a potentially curative opportunity without treating benign post-treatment change or causing disproportionate injury to previously irradiated thoracic organs.]]>2293false9fullhttps://www.spreaker.com/episode/thoracic-e08-high-risk-early-stage-nsclc-central-tumors-large-lesions-and-ild--73366219Episode 8 explores the modifiers that can turn apparently early-stage non-small cell lung cancer into a high-risk radiation problem: central or ultracentral anatomy, endobronchial extension, large tumor size, and fibrotic interstitial lung disease. These features can change candidacy, fractionation, target priorities, image guidance, consent, and whether an ablative plan should be offered at all.
Rather than asking for a single central-lung dose, we ask which anatomic or patient-specific risk should control the recommendation and how to protect critical serial organs without pretending that every tradeoff can be solved by technique alone.]]>c18c1cb7-7ba2-4918-b3f5-fb81f2d3e656Mon, 03 Aug 2026 03:03:55 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 8 explores the modifiers that can turn apparently early-stage non-small cell lung cancer into a high-risk radiation problem: central or ultracentral anatomy, endobronchial...Episode 8 explores the modifiers that can turn apparently early-stage non-small cell lung cancer into a high-risk radiation problem: central or ultracentral anatomy, endobronchial extension, large tumor size, and fibrotic interstitial lung disease. These features can change candidacy, fractionation, target priorities, image guidance, consent, and whether an ablative plan should be offered at all.
Rather than asking for a single central-lung dose, we ask which anatomic or patient-specific risk should control the recommendation and how to protect critical serial organs without pretending that every tradeoff can be solved by technique alone.]]>2300false8fullhttps://www.spreaker.com/episode/thoracic-e07-peripheral-lung-sbrt--73366187Episode 7 is a practical workshop in peripheral lung stereotactic body radiation therapy. We move from candidacy and respiratory-motion data to target construction, fractionation, chest-wall risk, intermediate-dose falloff, image guidance, and the question that matters at every fraction: can the team reproduce the geometry that made the plan acceptable?
The episode emphasizes why a small target and short course do not make this simple treatment. A geometric miss, hidden serial organ, unreliable motion envelope, or weak setup strategy carries a large biological consequence when each fraction delivers an ablative dose.]]>c5eaf8dd-2812-4d19-87a2-2abe7bfe2a20Mon, 03 Aug 2026 03:03:30 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 7 is a practical workshop in peripheral lung stereotactic body radiation therapy. We move from candidacy and respiratory-motion data to target construction, fractionation,...Episode 7 is a practical workshop in peripheral lung stereotactic body radiation therapy. We move from candidacy and respiratory-motion data to target construction, fractionation, chest-wall risk, intermediate-dose falloff, image guidance, and the question that matters at every fraction: can the team reproduce the geometry that made the plan acceptable?
The episode emphasizes why a small target and short course do not make this simple treatment. A geometric miss, hidden serial organ, unreliable motion envelope, or weak setup strategy carries a large biological consequence when each fraction delivers an ablative dose.]]>2426false7fullhttps://www.spreaker.com/episode/thoracic-e06-early-stage-non-small-cell-lung-cancer-treatment-selection--73366228Episode 6 tackles early-stage non-small cell lung cancer as a treatment-selection problem, not a reflex comparison of surgery versus stereotactic body radiation therapy. We begin by confirming localized, node-negative disease, pursuing tissue when safely feasible, separating medical operability from anatomic resectability, and defining the actual operation and radiation course being compared.
Using a growing, FDG-avid peripheral lesion as the anchor, we make the diagnostic, functional, perioperative, and toxicity tradeoffs explicit so that the final recommendation remains conditional, multidisciplinary, and aligned with the patient’s informed goals.]]>5c95a79a-861e-472f-bae2-69f63d6c40c3Mon, 03 Aug 2026 03:02:43 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 6 tackles early-stage non-small cell lung cancer as a treatment-selection problem, not a reflex comparison of surgery versus stereotactic body radiation therapy. We begin by...Episode 6 tackles early-stage non-small cell lung cancer as a treatment-selection problem, not a reflex comparison of surgery versus stereotactic body radiation therapy. We begin by confirming localized, node-negative disease, pursuing tissue when safely feasible, separating medical operability from anatomic resectability, and defining the actual operation and radiation course being compared.
Using a growing, FDG-avid peripheral lesion as the anchor, we make the diagnostic, functional, perioperative, and toxicity tradeoffs explicit so that the final recommendation remains conditional, multidisciplinary, and aligned with the patient’s informed goals.]]>2597false6fullhttps://www.spreaker.com/episode/thoracic-e05-simulation-respiratory-motion-and-image-guidance--73366195Episode 5 moves thoracic radiation from the planning scan to the reality of treating a breathing patient. We examine how simulation, respiratory-motion assessment, treatment position, image registration, beam delivery, and image guidance must describe the same physical situation for the plan to remain trustworthy.
The episode provides a safety workflow for choosing a reproducible motion strategy, verifying the target or a justified surrogate, recognizing workflow failure, and escalating when treatment no longer behaves as designed. Throughout, we balance geometric confidence against treatment burden and complexity.]]>760798f2-fb38-4a65-818d-5397d37dda89Mon, 03 Aug 2026 03:00:52 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 5 moves thoracic radiation from the planning scan to the reality of treating a breathing patient. We examine how simulation, respiratory-motion assessment, treatment position,...Episode 5 moves thoracic radiation from the planning scan to the reality of treating a breathing patient. We examine how simulation, respiratory-motion assessment, treatment position, image registration, beam delivery, and image guidance must describe the same physical situation for the plan to remain trustworthy.
The episode provides a safety workflow for choosing a reproducible motion strategy, verifying the target or a justified surrogate, recognizing workflow failure, and escalating when treatment no longer behaves as designed. Throughout, we balance geometric confidence against treatment burden and complexity.]]>1911false5fullhttps://www.spreaker.com/episode/thoracic-e04-operability-resectability-and-surgical-principles--73366197Episode 4 separates three questions that are too often collapsed into the phrase surgical candidate: Can the patient tolerate the proposed operation? Can the cancer be completely removed by a reasonable operation? And even if both are possible, is surgery the right oncologic strategy for this patient?
We apply those distinctions to pulmonary reserve, cardiac risk, frailty, extent of resection, nodal disease, margin feasibility, and patient preference. The result is a clearer way to defend curative surgery, a nonsurgical local option, or a multimodality sequence without hiding the real limiting factor.]]>ccc8f694-4f0a-4c4e-94f4-d7921679628eMon, 03 Aug 2026 03:00:21 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 4 separates three questions that are too often collapsed into the phrase surgical candidate: Can the patient tolerate the proposed operation? Can the cancer be completely removed...Episode 4 separates three questions that are too often collapsed into the phrase surgical candidate: Can the patient tolerate the proposed operation? Can the cancer be completely removed by a reasonable operation? And even if both are possible, is surgery the right oncologic strategy for this patient?
We apply those distinctions to pulmonary reserve, cardiac risk, frailty, extent of resection, nodal disease, margin feasibility, and patient preference. The result is a clearer way to defend curative surgery, a nonsurgical local option, or a multimodality sequence without hiding the real limiting factor.]]>2058false4fullhttps://www.spreaker.com/episode/thoracic-e03-nodal-anatomy-and-invasive-mediastinal-staging--73366212Episode 3 connects thoracic nodal anatomy to the decisions it changes: imaging probability, procedural access, specimen adequacy, stage, and treatment intent. The goal is not simply to memorize station numbers, but to know whether a suspicious node was named correctly, could be reached by the chosen procedure, and was truly represented by an adequate sample.
We build a practical approach to invasive mediastinal staging that helps you explain what was sampled, what remains uncertain, and how the result should alter surgery, radiation, or multimodality treatment.]]>2248524e-b4b7-408f-847d-1536e185d48dMon, 03 Aug 2026 02:59:14 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 3 connects thoracic nodal anatomy to the decisions it changes: imaging probability, procedural access, specimen adequacy, stage, and treatment intent. The goal is not simply to...Episode 3 connects thoracic nodal anatomy to the decisions it changes: imaging probability, procedural access, specimen adequacy, stage, and treatment intent. The goal is not simply to memorize station numbers, but to know whether a suspicious node was named correctly, could be reached by the chosen procedure, and was truly represented by an adequate sample.
We build a practical approach to invasive mediastinal staging that helps you explain what was sampled, what remains uncertain, and how the result should alter surgery, radiation, or multimodality treatment.]]>2704false3fullhttps://www.spreaker.com/episode/thoracic-e02-thoracic-imaging-and-tnm-staging--73366232Episode 2 turns thoracic imaging and TNM staging into a clinical reasoning exercise rather than a table-lookup task. We work through how to integrate imperfect studies, separate radiographic suspicion from pathologic proof, and assign a transparent, version-correct anatomic stage without treating missing information as negative information.
The episode uses the American Joint Committee on Cancer Version 9 framework and emphasizes a repeatable sequence: confirm the diagnosis, assess whether imaging answers the staging questions, assign T, N, and M categories, translate the completed triplet, and clearly state any management-changing uncertainty.]]>b8d0b9a0-52c7-4282-a7eb-5a8b831ee750Mon, 03 Aug 2026 02:57:45 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 2 turns thoracic imaging and TNM staging into a clinical reasoning exercise rather than a table-lookup task. We work through how to integrate imperfect studies, separate...Episode 2 turns thoracic imaging and TNM staging into a clinical reasoning exercise rather than a table-lookup task. We work through how to integrate imperfect studies, separate radiographic suspicion from pathologic proof, and assign a transparent, version-correct anatomic stage without treating missing information as negative information.
The episode uses the American Joint Committee on Cancer Version 9 framework and emphasizes a repeatable sequence: confirm the diagnosis, assess whether imaging answers the staging questions, assign T, N, and M categories, translate the completed triplet, and clearly state any management-changing uncertainty.]]>2551false2fullhttps://www.spreaker.com/episode/thoracic-e01-screening-pulmonary-nodules-and-tissue-diagnosis--73366208Episode 1 follows the clinical chain from lung-cancer screening and pulmonary-nodule evaluation to a tissue diagnosis that can actually guide treatment. We focus on the decisions that prevent downstream staging and planning errors: whether an abnormality belongs on a screening or diagnostic pathway, what to sample, how to judge tissue adequacy, and when additional workup will change management.
Use the episode to practice a board-ready four-question framework: define the likely diagnosis, establish the known disease extent, identify the uncertainty most likely to change management, and state the realistic treatment intent.]]>1e29a025-4915-4263-af3e-ca19f0b0e60fMon, 03 Aug 2026 02:54:23 +0000Abass ContehWelcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 1 follows the clinical chain from lung-cancer screening and pulmonary-nodule evaluation to a tissue diagnosis that can actually guide treatment. We focus on the decisions that...Episode 1 follows the clinical chain from lung-cancer screening and pulmonary-nodule evaluation to a tissue diagnosis that can actually guide treatment. We focus on the decisions that prevent downstream staging and planning errors: whether an abnormality belongs on a screening or diagnostic pathway, what to sample, how to judge tissue adequacy, and when additional workup will change management.
Use the episode to practice a board-ready four-question framework: define the likely diagnosis, establish the known disease extent, identify the uncertainty most likely to change management, and state the realistic treatment intent.]]>1869false1fullhttps://www.spreaker.com/episode/gu-e32-mock-oral-boards-penile-and-urethral-cancer-node-positive-and-preservation-cases--73249549In Episode 32, we conclude our distal GU module with a deep dive into Mock Oral Boards—focusing on Penile and Urethral Cancer, including node-positive presentations and organ-preservation strategies.
These rare malignancies are prime targets for board examinations because they require a disciplined, structured approach to staging, nodal logic, and complex radiation treatment sequencing. Rather than relying on memorized trivia, the examiner is testing your ability to synthesize clinical data and respect anatomical constraints.
In this episode, I will walk you through two primary case blocks presented in stages. I encourage you to pause after each question to formulate your own clinical response before listening to the model answer.]]>ec21f377-dd3c-4bd3-a87d-b2cc76acd57bThu, 30 Jul 2026 00:28:48 +0000Abass ContehWelcome back to Rad Onc Smart Review: Genitourinary Oncology Edition. In Episode 32, we conclude our distal GU module with a deep dive into Mock Oral Boards—focusing on Penile and Urethral Cancer, including node-positive presentations and...In Episode 32, we conclude our distal GU module with a deep dive into Mock Oral Boards—focusing on Penile and Urethral Cancer, including node-positive presentations and organ-preservation strategies.
These rare malignancies are prime targets for board examinations because they require a disciplined, structured approach to staging, nodal logic, and complex radiation treatment sequencing. Rather than relying on memorized trivia, the examiner is testing your ability to synthesize clinical data and respect anatomical constraints.
In this episode, I will walk you through two primary case blocks presented in stages. I encourage you to pause after each question to formulate your own clinical response before listening to the model answer.]]>2629falsefullhttps://www.spreaker.com/episode/gu-e27-case-based-review-rcc-mock-oral-solitary-kidney-ivc-and-oligoprogression--732495480dc6bb16-9561-45e3-a514-1c71ad8c3aeaThu, 30 Jul 2026 00:25:06 +0000Abass ContehWelcome back to Rad Onc Smart Review, Genitourinary Oncology edition. In Episode 27, we tackle a mock oral exam focused on Renal Cell Carcinoma (RCC), covering clinical scenarios involving a solitary kidney, IVC involvement, and oligoprogression. In...2309falsefullhttps://www.spreaker.com/episode/gu-e23-testicular-mock-oral-stage-i-stage-iia-and-nsgct-variants--73249552e1cc96eb-61b3-4a64-a88c-5842ee77fadaThu, 30 Jul 2026 00:22:33 +0000Abass ContehWelcome back to Rad Onc Smart Review, Genitourinary Oncology edition. This is Episode 23: Testicular Mock Oral - Stage I, Stage IIA, and NSGCT Variants. Today we cap our testicular block with a full mock oral boards session. I will present three case...2033falsefullhttps://www.spreaker.com/episode/gu-e18-bladder-mock-oral-trimodality-therapy-post-cystectomy-radiation-and-local-recurrence--73248880ca4599e6-ee9d-4d95-b87b-7ec95a591ba6Thu, 30 Jul 2026 00:19:02 +0000Abass ContehWelcome back to Rad Onc Smart Review, Genitourinary Oncology edition. This is Episode 18: Bladder Mock Oral - trimodality therapy, post-cystectomy radiation, and local recurrence. This is the capstone of the bladder block. The goal today is not just...2250falsefullhttps://www.spreaker.com/episode/gu-e12-case-based-review-prostate-cancer-mock-oral-boards--732488817ec1f556-d18f-4ac1-b567-01a96c12247eThu, 30 Jul 2026 00:17:04 +0000Abass ContehWelcome back to Rad Onc Smart Review: Genitourinary Oncology Edition. In Episode 12, we’re putting your knowledge to the test with a Case-Based Review: Prostate Cancer Mock Oral Boards.In this episode, I walk through three distinct case blocks...2990falsefullhttps://www.spreaker.com/episode/gu-e31-penile-and-urethral-planning-workshop--718250422e7b6b7b-14eb-4ef3-b62a-8f0b6425862fSat, 02 May 2026 04:00:21 +0000Abass ContehThis is Episode 31: Penile and Urethral Planning Workshop. These are rare, high-stakes plans. The anatomy is mobile, the setup can be awkward, the evidence base is limited, and sloppy field design can have major consequences. This workstation episode...2266falsefullhttps://www.spreaker.com/episode/gu-e30-penile-cancer-primary-management-nodes-organ-preservation--71825045cc859e16-6117-4065-b782-2ad1f82aff24Sat, 02 May 2026 03:59:09 +0000Abass ContehThis is Episode 30: Penile Cancer Primary Management, Nodes, and Organ Preservation.Penile cancer is rare, but it is very fair game on boards because it tests whether you can keep anatomy, staging, nodal logic, and quality-of-life tradeoffs straight...2041falsefullhttps://www.spreaker.com/episode/gu-e29-urethral-cancer-staging-and-multimodality-management--7182504672d01a70-7386-41db-a0ce-775954de3582Sat, 02 May 2026 03:57:25 +0000Abass ContehToday we will build a practical framework for workup, staging, histology, and multimodality management. We will also cover where radiation fits, including selected use of brachytherapy for early-stage female disease and definitive chemoradiation for...2587falsefullhttps://www.spreaker.com/episode/gu-e28-upper-tract-urothelial-carcinoma--71825050306b2045-18a9-4916-8df2-093fbcc61e1dSat, 02 May 2026 03:54:34 +0000Abass ContehThis is Episode 28: Upper Tract Urothelial Carcinoma perioperative therapy, patterns of failure, and where radiation enters the conversation.UTUC is one of those diseases that residents do not see often, but oral examiners love it because it looks...2675falsefullhttps://www.spreaker.com/episode/gu-e26-rcc-planning-workshop-primary-and-metastatic-sbrt-cases--7182504435a8df5a-716b-4a41-91cf-07ea9dd9e881Sat, 02 May 2026 03:52:33 +0000Abass ContehThis is the workstation episode. This is the planning episode. The big idea is simple: kidney SBRT is usually a motion-management problem and an organ-at-risk problem before it becomes a dose problem. Your bowel, your duodenum, your stomach, and the...2716falsefullhttps://www.spreaker.com/episode/gu-e25-rcc-oligometastatic-disease-the-ici-era-and-cytoreduction--718250432174f0bc-716d-4061-83fa-8756f2b97c59Sat, 02 May 2026 03:49:55 +0000Abass ContehThis is one of the highest-yield modern RCC topics because it sits right where three practice changes collide. First, RCC was long treated as a disease that did not respond well to conventional radiation, but modern ablative radiation changed that...2600falsefullhttps://www.spreaker.com/episode/gu-e24-rcc-localized-disease-surgery-ablation-primary-sbrt--718250544a3898ef-bf90-4741-a6fd-aaed52d0e4efSat, 02 May 2026 03:44:42 +0000Abass ContehThis is Episode 24: Renal Cell Carcinoma Localized Disease, Surgery, Ablation, and Primary SBRT. Here is the modern frame. Localized RCC is still primarily a surgical disease. Conventional fractionation never established a curative or adjuvant role in...2170falsefullhttps://www.spreaker.com/episode/gu-e22-testicular-fertility-toxicity-follow-up-failure-patterns--7182504815f3f94a-7621-4ad7-a05d-4f522b78af52Sat, 02 May 2026 03:43:29 +0000Abass ContehThis episode is about what happens after cure. Testicular cancer is one of the great success stories in oncology, but that success creates a second job: taking care of survivors for decades. These are often young men with excellent cure rates and long...1963falsefullhttps://www.spreaker.com/episode/gu-e21-testicular-advanced-gct-residual-masses-and-salvage-strategy--71825047958e0833-673e-4c3e-bf70-717e5d8b5404Sat, 02 May 2026 03:42:15 +0000Abass ContehThis is the episode where testicular cancer stops being mostly about stage I and stage II decision trees and starts becoming a sequencing problem. The questions are no longer just surveillance versus adjuvant therapy. Now the important questions are:...2479falsefullhttps://www.spreaker.com/episode/gu-e20-testicular-stage-ii-seminoma-nsgct-and-field-design--71580587fedc36a2-3a56-4fc8-be05-225e500aa9b1Thu, 23 Apr 2026 01:48:51 +0000Abass ContehThis is Episode 20: Testicular Stage II Seminoma, NSGCT, and Field Design. Last episode, we built the foundation: markers, orchiectomy, staging, and why surveillance is preferred for most stage I seminoma. Today we move into stage II disease, where...2562falsefullhttps://www.spreaker.com/episode/gu-e19-testicular-cancer-workup-markers-staging-and-stage-i-seminoma--7158058680201857-cc5e-433d-b70b-267baf8c88d3Thu, 23 Apr 2026 01:47:19 +0000Abass ContehThis is Episode 19: Testicular Cancer - Workup, Markers, Staging, and Stage I Seminoma. Testicular cancer is uncommon overall, but it is the most common solid malignancy in young men, and it is one of the great cure stories in oncology. That changes...2017falsefullhttps://www.spreaker.com/episode/gu-e17-metastatic-urothelial-cancer-immunotherapy-and-future-directions--715805913845ae5c-4013-433c-a836-bb05df0e8530Thu, 23 Apr 2026 01:46:05 +0000Abass ContehThis is Episode 17: metastatic urothelial cancer, immunotherapy, and future directions. This is one of the fastest-moving areas in GU oncology. For years, first-line treatment for metastatic urothelial cancer meant platinum-based chemotherapy, with...2446falsefullhttps://www.spreaker.com/episode/gu-e16-bladder-post-cystectomy-radiation-follow-up-and-salvage-pathways--715805956f8fa833-d90a-497d-a588-fcf4f9acd784Thu, 23 Apr 2026 01:44:41 +0000Abass ContehThis is Episode 16: Bladder Post-Cystectomy Radiation, Follow-Up, and Salvage Pathways. This episode is high-yield because it addresses two common bladder cancer mistakes. First, it corrects the simplistic answer that radiation has no role after...2569falsefullhttps://www.spreaker.com/episode/gu-e15-bladder-planning-workshop-definitive-preservation-cases--71580590fef1f169-15c5-426b-8e10-4f7559ec0dceThu, 23 Apr 2026 01:43:23 +0000Abass ContehThis is Episode 15: Bladder Planning Workshop - Definitive Preservation Cases. The last episode focused on who qualifies for trimodality therapy and why concurrent chemoradiation is preferred over radiation alone. Today's planning episode covers how...2676falsefullhttps://www.spreaker.com/episode/gu-e14-bladder-trimodality-therapy-radiosensitizers-and-hypofractionation--71580596b6477dd5-86b4-4ae8-9f67-5229a1e0b193Thu, 23 Apr 2026 01:41:46 +0000Abass ContehThis is Episode 14: Bladder Trimodality Therapy, Radiosensitizers, and Hypofractionation. Here's the key takeaway: bladder-preserving trimodality therapy is a viable curative option, not a last resort. In the right patients, it's a legitimate...2595falsefullhttps://www.spreaker.com/episode/gu-e13-bladder-cancer-nmibc-mibc-workup-and-the-surgical-backbone--7158058957d8f7d8-43d3-496e-8a21-6bcfa798baf7Thu, 23 Apr 2026 01:40:41 +0000Abass ContehThis is Episode 13: Bladder Cancer – Non-Muscle-Invasive and Muscle-Invasive Workup and the Surgical Backbone. Here's why this episode matters: Bladder cancer is a disease where radiation oncologists can be indispensable members of a curative...2109falsefullhttps://www.spreaker.com/episode/gu-e11-prostate-follow-up-toxicity-survivorship-and-failure-patterns--71580599c7ec168f-f525-437d-85c0-88037f3ad192Thu, 23 Apr 2026 01:39:04 +0000Abass ContehThis is Episode 11: Prostate Follow-up, Toxicity, Survivorship, and Failure Patterns. This is a high-yield episode because most prostate teaching focuses on the front end: risk stratification, dose, fractionation, and ADT duration. However, in the...2527falsefullhttps://www.spreaker.com/episode/gu-e10-prostate-planning-workshop-intact-post-op-and-nodal-cases--7158059293b5f5ba-ef5a-4e98-8a21-2f9a10caab3dThu, 23 Apr 2026 01:37:59 +0000Abass ContehThis is Episode 10: Prostate Planning Workshop intact, post-op, and nodal cases. For the last several episodes, we've discussed what to treat in prostate cancer – risk groups, ADT duration, brachy boost candidates, and salvage triggers. Today, we're...2656falsefullhttps://www.spreaker.com/episode/gu-09-prostate-mhspc-crpc-mdt-and-precision-systemic-therapy--715805971a55020c-5a53-4634-b052-eef5012d4aceThu, 23 Apr 2026 01:36:29 +0000Abass ContehWelcome back to Rad Onc Smart Review, Genitourinary Oncology edition. This is Episode 9: a discussion on prostate cancer across the metastatic continuum, including metastatic hormone-sensitive disease, nonmetastatic castration-resistant disease,...2329falsefullhttps://www.spreaker.com/episode/gu-e08-prostate-salvage-after-surgery-rt-and-focal-therapy--71580600f1575476-a37b-46bf-9a8b-499a5164c71bThu, 23 Apr 2026 01:34:55 +0000Abass ContehEpisodes 3 through 7 covered definitive treatment. This episode covers what to do when definitive treatment fails. After prostatectomy, earlier salvage RT at lower PSA is associated with better outcomes. After prior RT or focal therapy, salvage can...2126falsefullhttps://www.spreaker.com/episode/gu-e04-prostate-definitive-ebrt-dose-escalation-moderate-hypofractionation--71171997ba2e0c57-c1b8-4c70-bbc1-cd0cba5960fbTue, 31 Mar 2026 15:24:00 +0000Abass ContehThe first three episodes established the foundation – anatomy, risk groups, workup, and surveillance. Now, we begin treatment. This episode explores the physics and biology of dose delivery to the prostate. We'll cover three key areas: First, the...4115falsefullhttps://www.spreaker.com/episode/gu-e07--71022875627cd363-1010-4625-bfdb-d465d27d3931Tue, 31 Mar 2026 15:23:17 +0000Abass ContehE07 Draft2837falsefullhttps://www.spreaker.com/episode/gu-e06--71022877f4738c77-6e58-4273-97bd-b9849badae1aTue, 31 Mar 2026 15:22:33 +0000Abass ContehE06 draft2913falsefullhttps://www.spreaker.com/episode/gu-e05--71022878ff623e45-9e11-493b-b08e-bc4f6c0656a9Tue, 31 Mar 2026 15:21:52 +0000Abass ContehE05 draft2988falsefullhttps://www.spreaker.com/episode/gu-e03--71022880d7f34b22-3479-4559-86dd-641dc268e3ffTue, 31 Mar 2026 15:21:14 +0000Abass ContehEpisode 3 draft3544falsefullhttps://www.spreaker.com/episode/gu-e02--71022876f90764a9-11fc-47b6-b4dd-f3b8e1508f90Tue, 31 Mar 2026 15:20:17 +0000Abass ContehEpisode 2 draft3081falsefullhttps://www.spreaker.com/episode/gu-e01-prostate-anatomy-pathology-risk-groups-natural-history--71015573276277bf-f828-40bd-ba6a-50f2465d516eTue, 31 Mar 2026 07:52:06 +0000Abass ContehThis is Episode 1: Prostate – Anatomy, Pathology, Risk Groups, and Natural History. This foundational episode covers everything in the prostate series – dose escalation, hypofractionation, brachytherapy, ADT integration, salvage, and oligometastatic...2854falsefullhttps://www.spreaker.com/episode/h-n-e39a-sinonasal-ii-maxillary-and-ethmoid-scc-and-snuc-management--7010150482b5bad2-6cfc-43e9-b910-580b940bee3bTue, 17 Feb 2026 15:06:06 +0000Abass ContehThis is Episode 39a: Sinonasal II Maxillary and Ethmoid SCC and SNUC Management. In our last episode, we established the anatomic and histologic foundations for sinonasal cancers. Now, we apply that knowledge. This clinical decision-making episode...2318falsefullhttps://www.spreaker.com/episode/h-n-e38a-sinonasal-i-anatomy-histology-diversity-and-multimodality-logic--70074553fae74d01-061d-4615-a337-f41ea5f740faMon, 16 Feb 2026 00:09:12 +0000Abass ContehThis is Episode 38: Sinonasal I Anatomy, Histology Diversity, and Multimodality Logic. We are now entering a block of head and neck oncology that is genuinely unique. Sinonasal cancers represent fewer than 2,000 cases per year in the United States —...1735falsefullhttps://www.spreaker.com/episode/h-n-e37b-salivary-gland-capstone-mock-oral-board-review--7001073803bda686-378e-40ed-8d7d-8c31afc0efe0Thu, 12 Feb 2026 08:29:48 +0000Abass ContehToday we simulate the oral boards exam in three clinical blocks plus a lightning round. Block One walks through comprehensive postoperative management. Blocks Two and Three test specific decision pivots, perineural invasion stop points and metastatic...1802falsefullhttps://www.spreaker.com/episode/h-n-e37a-salivary-gland-iv-unresectable-disease-and-advanced-approaches--70010739733e4b9a-aaa6-4618-b594-a9773e97725fThu, 12 Feb 2026 08:28:32 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 37: Salivary Gland Four – Unresectable Disease and Advanced Approaches. This episode completes our Salivary Gland block. We have built the foundation – histology-driven...2261falsefullhttps://www.spreaker.com/episode/h-n-e36-salivary-gland-iii-perineural-invasion-and-named-nerve-strategy--700107400e45d8e6-0779-4685-8760-87051c1cc9dcThu, 12 Feb 2026 08:27:06 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 36: Salivary Gland Three — Perineural Invasion and Named Nerve Strategy. Perineural invasion is the defining challenge of salivary gland radiation oncology. It is why adenoid...1572falsefullhttps://www.spreaker.com/episode/h-n-e35-salivary-gland-ii-adjuvant-rt-triggers-and-planning--70010741b9f57c86-44fb-4153-a4cc-7c3cc0e9e045Thu, 12 Feb 2026 08:25:46 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 35: Salivary Gland Two — Adjuvant RT Triggers and Planning. In Episode 34, we built the salivary gland paradigm: histology leads, surgery is primary, and adjuvant decisions...1673falsefullhttps://www.spreaker.com/episode/h-n-e34-salivary-gland-i-histology-driven-biology-and-the-surgical-paradigm--70009263085d2cbb-c57c-4954-ace1-13b5ecb154e6Thu, 12 Feb 2026 08:24:20 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 34: Salivary Gland One — Histology-Driven Biology and the Surgical Paradigm. This episode launches our salivary gland block, and I want to be direct: salivary gland cancers...1954falsefullhttps://www.spreaker.com/episode/h-n-e33-hypopharynx-integration-decision-points-and-surveillance--6978276983ec0bdd-a6b2-4fc4-9783-731c65481e2cWed, 04 Feb 2026 08:38:33 +0000Abass ContehThis is Episode 33: Hypopharynx Integration Decision Points and Surveillance. Episode 31 covered the biology, including the worst-actor paradigm, prognosis, and the four defaults. Episodes 32 and 32b focused on planning: contouring, extension, and...1863falsefullhttps://www.spreaker.com/episode/h-n-e32b-hypopharynx-planning-workshop--6978277271b5b725-5bbf-4d39-9fa4-73b72aca4aedWed, 04 Feb 2026 08:36:28 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 32b: Hypopharynx Planning Workshop. Episode 32 gave you the rules, the four defaults, the nodal template, the inferior extent ladder, and the OAR priorities. Today, we build...2013falsefullhttps://www.spreaker.com/episode/h-n-e32-hypopharynx-ii-treatment-planning-and-cervical-esophagus-extension--697827716f429d38-b671-4257-aab2-d8ac379786abWed, 04 Feb 2026 08:34:41 +0000Abass ContehIn Episode 31, we established the foundational paradigm for hypopharyngeal cancer, the worst-actor subsite in head and neck oncology. We defined four defaults that govern our approach to these cases: Default one: retropharyngeal nodes on. Default two:...1964falsefullhttps://www.spreaker.com/episode/h-n-e31-hypopharynx-i-anatomy-prognosis-and-the-worst-actor-paradigm--69782770e18068f3-ed62-4626-a098-c671c1a9565bWed, 04 Feb 2026 08:32:37 +0000Abass ContehThis is Episode Thirty-One: Hypopharynx One — Anatomy, Prognosis, and the Worst-Actor Paradigm. Today we tackle the subsite that earns its reputation as the worst actor in head and neck oncology. Hypopharyngeal cancer presents late, spreads early, and...2110falsefullhttps://www.spreaker.com/episode/h-n-e30-larynx-capstone-mock-oral-board-review--697121289fb93695-4c38-4679-8366-bdfce30329b1Sat, 31 Jan 2026 20:40:11 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 30: Larynx Capstone – Mock Oral Board Review. Today we simulate the oral boards exam in four clinical blocks. Each block features a case that escalates through workup,...1580falsefullhttps://www.spreaker.com/episode/h-n-e29-advanced-larynx-t4a-and-the-unpreservable--69586669afb3141b-494c-4aa6-8470-d6c01f85822bMon, 26 Jan 2026 03:08:46 +0000Abass ContehThis episode, number 29, focuses on Advanced Larynx T4a and the Unpreservable. Building upon Episode 28's discussion of organ preservation, we explore instances where such preservation is not the optimal course of action. Specifically, we examine how...1892falsefullhttps://www.spreaker.com/episode/h-n-e28-organ-preservation-the-landmark-trials--69586668809f2026-f046-4f7a-a352-7482b0afb3feMon, 26 Jan 2026 03:07:25 +0000Abass ContehThis episode, number 28, explores "Organ Preservation: The Landmark Trials." Prior to 1991, the standard treatment for advanced laryngeal cancer involved total laryngectomy and radiation, which, while ensuring patient survival, resulted in the loss of...1885falsefullhttps://www.spreaker.com/episode/h-n-e27b-early-larynx-planning-workshop--695866705f0295d1-fb9a-4097-877e-607c20fe2525Mon, 26 Jan 2026 03:05:24 +0000Abass ContehThis is Episode 27b: Early Larynx Planning Workshop. In Episode 27, we addressed the fundamental aspects, including the radiocurability of early glottic cancer, the standard fractionation of 2.25 Gy/fx, and the rationale for neck sparing due to a...1946falsefullhttps://www.spreaker.com/episode/h-n-e27-early-glottic-cancer-fields-fractionation-and-voice-preservation--695866713625bd6f-896b-455f-81bf-21ea12724797Mon, 26 Jan 2026 03:03:15 +0000Abass ContehThis is Episode 27: Early Glottic Cancer Fields, Fractionation, and Voice Preservation. Early glottic cancer represents the prototype of a radiation-curable malignancy. It is one of the few oncological sites where we routinely achieve patient cures...2012falsefullhttps://www.spreaker.com/episode/h-n-e26-larynx-i-anatomy-staging-and-the-organ-preservation-philosophy--6958667211b3442a-7ed2-4e98-83c9-9e347ed432b5Mon, 26 Jan 2026 03:01:21 +0000Abass ContehThis is Episode 26: Larynx I- Anatomy, Staging, and the Organ Preservation Philosophy. The larynx holds a unique position in head and neck oncology. It is the one subsite where we routinely achieve cancer cures while preserving organ function. In...1520falsefullhttps://www.spreaker.com/episode/h-n-e25-nasopharynx-capstone-mock-oral-boards--69576792a706fd86-10c3-41b1-84b7-f57a546dea8fSun, 25 Jan 2026 02:30:55 +0000Abass ContehThis is Episode 25: Nasopharynx Capstone – Mock Oral Boards. Today, we will simulate the oral board examination through four clinical blocks. Each block presents a case that progresses from workup to staging, treatment selection, planning priorities,...1158falsefullhttps://www.spreaker.com/episode/h-n-e24b-the-nasopharynx-planning-workshop-focuses-on-skull-base-abutment-cases--69576795eadf3791-1f2e-47e5-89c9-ced95d4091e0Sun, 25 Jan 2026 02:27:19 +0000Abass ContehThis is Episode 24b: The Nasopharynx Planning Workshop, which focuses on skull base abutment cases. In the preceding episodes, we established the clinical framework for nasopharyngeal carcinoma, encompassing anatomy, staging, EBV biology, systemic...1471falsefullhttps://www.spreaker.com/episode/h-n-e24-nasopharynx-iv-response-assessment-and-salvage--6957679494c2222d-68f4-4acd-8de5-9b3b3bab2a59Sun, 25 Jan 2026 02:23:00 +0000Abass ContehThis is Episode 24: Nasopharynx IV Response Assessment and Salvage. Building upon the previous two episodes, we have established that nasopharyngeal carcinoma is a radiation-driven disease. We have reviewed the anatomy, EBV biology, staging, and...1420falsefullhttps://www.spreaker.com/episode/h-n-e23-nasopharynx-iii-induction-and-concurrent-systemic-therapy--69576630d555a414-c1e4-4c1e-9f3f-c6b45ad92ec7Sun, 25 Jan 2026 02:15:50 +0000Abass ContehThis episode, number 23, focuses on Nasopharynx III Induction and Concurrent Systemic Therapy. Building on Episode 22, where we established NPC as a radiation-driven disease with unique anatomy and EBV biology, and Episode 22b, where we covered target...1678falsefullhttps://www.spreaker.com/episode/h-n-e22b-nasopharynx-ii-target-volume-masterclass--6954393344df0d5c-17ce-4f13-bbdf-6cf7a7e69b1eThu, 22 Jan 2026 08:32:27 +0000Abass ContehIn Episode 22, we framed nasopharyngeal carcinoma as a radiation-driven disease with distinct anatomy, EBV association, and AJCC 8 edition staging built around skull base landmarks. Now we do the part that oral boards loves: designing the plan.1773falsefullhttps://www.spreaker.com/episode/h-n-e22-nasopharynx-i-anatomy-ebv-biology-and-the-definitive-rt-paradigm--695439345d39cf5c-11b0-4c5a-a70e-bb9278ae767aThu, 22 Jan 2026 08:30:41 +0000Abass ContehThis is Episode 22: Nasopharynx I Anatomy, E. B. V. Biology, and the Definitive R. T. Paradigm. Nasopharyngeal carcinoma is a board-favorite because it behaves unlike the rest of the head and neck. It is a radiation-first disease with skull base...1605falsefullhttps://www.spreaker.com/episode/h-n-e21-oropharynx-capstone-mock-oral-boards--6952738552801efe-654e-43be-a0d9-83d51d8adce6Wed, 21 Jan 2026 03:48:32 +0000Abass ContehThis is Episode 21: Oropharynx Capstone Mock Oral Boards. Today, we simulate the oral boards exam in five clinical blocks. Each block features a longitudinal case that escalates through workup, staging, treatment selection, planning priorities, and...1810falsefullhttps://www.spreaker.com/episode/h-n-e20-functional-outcomes-survivorship-in-oropharyngeal-cancer--69490328ec1c02a0-e5fd-490a-886a-d3f5b7d0bba6Sat, 17 Jan 2026 19:17:41 +0000Abass ContehThis is Episode 20: Functional Outcomes and Survivorship in Oropharyngeal Cancer. Today is about what boards actually test when they say “survivorship”: whether you understand the *functional price* of cure, and whether you can prove you planned...2138falsefullhttps://www.spreaker.com/episode/h-n-e19-h-pv-negative-oropharynx-unknown-primary-and-salvage-strategies--69434112119654ec-9068-4bbf-985e-1fc0bfb30b78Wed, 14 Jan 2026 08:09:24 +0000Abass ContehToday is the curveball episode. Boards love these scenarios because they test judgment, sequencing, and restraint. We will do three things. First, we will contrast the tobacco-associated, p16-negative oropharynx patient with the favorable HPV-positive...2584falsefullhttps://www.spreaker.com/episode/h-n-e18b-post-op-oropharynx-planning-workshop--69434111be054fc0-4eaa-4712-96ad-173801187ecaWed, 14 Jan 2026 07:49:23 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 18B: The Post-Operative Oropharynx Planning Workshop. Episode Eighteen was the clinic decision: who gets observation, who gets P-O-R-T, and who needs post-op chemoradiation...1721falsefullhttps://www.spreaker.com/episode/h-n-e18-oropharynx-tors-and-de-escalation--6939911819d0b311-6d01-42f8-b4e0-b3ed7e80396fMon, 12 Jan 2026 08:10:01 +0000Abass ContehThis is Episode 18: TORS and De-Escalation. Today we tackle one of the most controversial and actively evolving areas in head and neck oncology: the role of transoral robotic surgery and treatment de-intensification for H-P-V-positive oropharyngeal...2681falsefullhttps://www.spreaker.com/episode/h-n-e17b-oropharynx-definitive-planning-workshop-simulation-target-volumes-and-oar-constraints--693991203604b26c-2bd0-43bb-b58d-978c2e881542Mon, 12 Jan 2026 08:06:12 +0000Abass ContehThis is Episode 17b: Definitive Planning Workshop Simulation, Target Volumes, and OAR Constraints. In Episode 17, we covered the clinical decision-making for definitive chemoradiation—why we treat, who needs systemic therapy, and which agent to use....2717falsefullhttps://www.spreaker.com/episode/h-n-e17-oropharynx-definitive-chemo-rt-and-cisplatin-is-king--693991190b4ac507-c40a-49b6-b23f-b61192c713c1Mon, 12 Jan 2026 08:00:51 +0000Abass ContehThis is Episode 17: Definitive Chemo-RT Cisplatin is King. This episode is essential for boards. If you remember one thing from today, let it be this: *cisplatin is king*. Concurrent cisplatin with radiation is the standard of care for locally...2633falsefullhttps://www.spreaker.com/episode/h-n-e16-oropharynx-foundations--69373568fcb4bf13-8000-4936-9385-d1d6dffb0d3eFri, 09 Jan 2026 15:40:54 +0000Abass ContehThis is Episode sixteen: Oropharynx Foundations, H.P.V. Biology, and A.J.C.C. Eighth Edition Staging.Today we begin a new block, and I want to set the stage with something fundamental: oropharynx cancer is not one disease. It is two biologically...1654falsefullhttps://www.spreaker.com/episode/h-n-e15c-oral-cavity-capstone-mock-oral-boards--6933846923c26c85-5065-4941-9838-e280e7c28c53Wed, 07 Jan 2026 08:35:40 +0000Abass ContehToday, we simulate the oral board exam in five blocks. Each block has a multi-step main case, then a shorter twist that tests a different high-yield decision point for the same scenario. Treat this as a live exam. Pause after each question to...1885falsefullhttps://www.spreaker.com/episode/h-n-e15b-subsite-specific-coverage-for-oral-cavity-cancer--693037805040264d-1cf3-44ba-9169-0e161b1ccb57Mon, 05 Jan 2026 07:23:08 +0000Abass ContehThis is Episode 15B: Subsite-Specific Coverage for Oral Cavity Cancer. You’re sitting at the contouring workstation with a post-operative oral cavity case loaded. The C-T simulation is fused with the best available preoperative imaging. The surgeon...2483falsefullhttps://www.spreaker.com/episode/h-n-e15a-perineural-invasion-tracking-and-skull-base-extension--692854602be6ca27-503f-43f9-9793-5a23650a3556Sat, 03 Jan 2026 02:27:10 +0000Abass ContehThis is Episode 15A: Perineural Invasion Tracking and Skull Base Extension.The pathology report lands on your desk: “Extensive perineural invasion involving a named nerve measuring zero-point-three millimeters in diameter. Inferior alveolar nerve...2387falsefullhttps://www.spreaker.com/episode/h-n-e14c-definitive-radiation-and-brachytherapy-for-oral-cavity-cancer--69283012b35bc553-c20b-4075-805c-2a6925741053Fri, 02 Jan 2026 19:40:43 +0000Abass ContehThis is Episode 14C: Definitive Radiation and Brachytherapy for Oral Cavity Cancer.Throughout this oral cavity series, we’ve emphasized one principle above all: oral cavity cancer is a surgical disease. Surgery first. Radiation in the adjuvant...2323falsefullhttps://www.spreaker.com/episode/h-n-e14b-planning-with-reconstruction-flaps-hardware-and-the-o-r-n--69265747dc477dbb-9fd1-4279-8d84-44d07d99aaa5Thu, 01 Jan 2026 07:22:09 +0000Abass ContehThis is Episode fourteen B: Planning with Reconstruction - Flaps, Hardware, and the O.R.N. Trade-Off.In Episode eleven B, we built your planning vocabulary: simulation, volumes, nodal levels, and O.A.R. priorities. But that episode assumed a...2167falsefullhttps://www.spreaker.com/episode/h-n-e11b-oral-cavity-sim-and-volume--69263262d119eeee-f028-41f6-8fb6-2223c1f66ce1Wed, 31 Dec 2025 20:24:01 +0000Abass ContehIn Episode eleven A, we established that oral cavity cancer is a surgical disease. We learned the anatomy, the staging, and why surgery wins. But here's the thing: when pathology comes back with adverse features, you become the treating physician. And...2023falsefullhttps://www.spreaker.com/episode/h-n-e14-oral-cavity-four-mandible-reconstruction-and-bone-invasion-pitfalls--692208733442fa48-edaa-4beb-b366-5240a6b8da81Sat, 27 Dec 2025 16:08:52 +0000Abass ContehThis is Episode fourteen: Oral Cavity Four — Mandible, Reconstruction, and Bone Invasion Pitfalls.In the previous three episodes, we covered oral cavity anatomy, surgical management, the neck decision, and adjuvant therapy principles. Now we need to...1834falsefullhttps://www.spreaker.com/episode/h-n-e13-oral-cavity-three-port-versus-post-op-chemo-rt-the-big-two--69220874c67c088c-2abc-4df3-99e1-a2dee3cbd7e6Sat, 27 Dec 2025 15:42:03 +0000Abass ContehThis is Episode thirteen: Oral Cavity Three — PORT versus Post-op Chemo-RT: The "Big Two."In the last two episodes, we established that oral cavity cancer is a surgical disease and that the clinically node-negative neck requires elective treatment...2299falsefullhttps://www.spreaker.com/episode/h-n-e12-oral-cavity-two-the-clinically-node-negative-neck-elective-dissection-not-watchful-waiting--692203389280374b-0d2d-46af-ab0e-9e5f00df4249Sat, 27 Dec 2025 14:40:02 +0000Abass ContehThis is Episode twelve: Oral Cavity Two — The Clinically Node-Negative Neck: Elective Dissection, Not Watchful Waiting.In Episode Eleven, we established that oral cavity cancer is a surgical disease and that depth of invasion drives staging and...2069falsefullhttps://www.spreaker.com/episode/h-n-e11-oral-cavity-one-subsites-depth-of-invasion-and-why-surgery-usually-wins--69218933ed59953d-3c47-4e49-a2ec-a350eefbed8aSat, 27 Dec 2025 11:00:10 +0000Abass ContehThis is Episode eleven: Oral Cavity One — Subsites, Depth of Invasion, and Why Surgery Usually Wins.Over the next four episodes, we're going to master oral cavity cancer from the perspective of the radiation oncologist preparing for boards. And I want...1809falsefullhttps://www.spreaker.com/episode/h-n-e10-foundations-ix-planning-workshop-imrt-vmat-protons-and-oar-priorities--69217340427b10a4-ecd2-4a69-9b22-ab31d1fe745eSat, 27 Dec 2025 08:05:29 +0000Abass ContehThis is Episode 10: Foundations IX — Planning Workshop: IMRT, VMAT, Protons, and OAR Priorities.We’ve arrived at the “dark room” episode. Up to now, you’ve made clinical decisions: diagnosis, stage, intent, dose, and fractionation. Now you’re at the...2060falsefullhttps://www.spreaker.com/episode/h-n-e09-foundations-viii-supportive-care-ii-swallow-aspiration-trismus-and-osteoradionecrosis--69217339e38ae2fc-e8cf-4e3a-b0c1-55882e09dcc9Sat, 27 Dec 2025 08:04:14 +0000Abass ContehThis is Episode 9: Foundations VIII — Supportive Care II: Swallow, Aspiration, Trismus, and Osteoradionecrosis.Last episode was: “Don’t lose the patient during treatment.”This episode is: “Don’t ruin the next thirty years of their life.”Head and neck...1759falsefullhttps://www.spreaker.com/episode/h-n-e08-foundations-vii-supportive-care-i-dental-nutrition-and-mucositis--6921734522c57f6b-b6a0-463f-ab08-991925c5490aSat, 27 Dec 2025 08:02:52 +0000Abass ContehThis is Episode 8: Foundations VII — Supportive Care I: Dental, Nutrition, and Mucositis.We have spent the last seven episodes talking about how to kill the cancer. Today, we talk about how to keep the patient alive while we do it. On oral boards,...1926falsefullhttps://www.spreaker.com/episode/h-n-e07-foundations-vi-systemic-therapy-with-rt-cisplatin-cetuximab-and-alternatives--6921734227827875-fc9c-4160-88a5-13b5aa7bbb73Sat, 27 Dec 2025 08:02:00 +0000Abass ContehThis is Episode 7: Foundations VI — Systemic Therapy With RT: Cisplatin, Cetuximab, and Alternatives.We’ve built the scaffolding: anatomy, staging, and fractionation. Now we add the lever that most reliably increases cure rates in locally advanced...1618falsefullhttps://www.spreaker.com/episode/h-n-e06-foundations-v-fractionation-and-time-why-we-don-t-treat-head-and-neck-like-prostate--69217343651caee7-dd4e-42ba-b085-48056beeec48Sat, 27 Dec 2025 08:01:01 +0000Abass ContehThis is Episode 6: Foundations V — Fractionation and Time: Why We Don’t Treat Head and Neck Like Prostate.In prostate cancer, a week off for a holiday can be inconvenient, but the tumor biology barely flinches. In head and neck squamous cell...2040falsefullhttps://www.spreaker.com/episode/h-n-e05-foundations-iv-ajcc-staging-that-actually-changes-management--692158402a92b414-f191-4429-a77a-2aefcea79036Sat, 27 Dec 2025 01:30:22 +0000Abass ContehThis is Episode 5: Foundations IV — AJCC Staging That Actually Changes Management.Most residents treat staging as paperwork—something you fill out after you’ve already decided the plan. That’s backward. In AJCC Eighth Edition, staging is a decoder...2052falsefullhttps://www.spreaker.com/episode/h-n-e04-unknown-primary-the-neck-mass-without-a-mucosal-home--69215839a55b85d4-fa3c-4d60-86e0-ee7ccbadce08Sat, 27 Dec 2025 01:29:11 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition.This is Episode 4: Unknown Primary — The Neck Mass Without a Mucosal Home.In the last episode, we talked about the workup. We scoped, we scanned, and we biopsied. Most of the time, that...1932falsefullhttps://www.spreaker.com/episode/h-n-e03-foundations-iii-workup-masterclass-scope-pet-pan-endo-and-biomarkers--6921584395e88258-9f25-4b1a-bf75-bee5496d720fSat, 27 Dec 2025 01:27:44 +0000Abass ContehWelcome back to Rad Onc Smart Review, Head and Neck edition. This is Episode 3: Foundations III — Workup Masterclass: Scope, PET, Pan endo, and Biomarkers.Today is about the discipline of diagnosis.On oral boards, there is a specific way to fail a...1706falsefullhttps://www.spreaker.com/episode/h-n-e02-foundations-ii-cranial-nerves-pni-highways-and-the-skull-base--69215841c2f56544-173e-45e1-bea4-edaf5b321299Sat, 27 Dec 2025 01:25:54 +0000Abass ContehThis is Episode 2: Foundations II — Cranial Nerves, PNI Highways, and the Skull Base.**Last episode, we mapped lymphatics. Today, we map nerves.Because in head and neck oncology, **perineural invasion is not just a pathology word. It is geography.**...2106falsefullhttps://www.spreaker.com/episode/h-n-e01-foundations-i-neck-levels-and-spaces-that-change-volumes--6921584209c785f1-8c8e-42e6-94d2-b39ffbe674b2Sat, 27 Dec 2025 01:24:42 +0000Abass ContehThis is Episode 1: Foundations I — Neck Levels and Spaces That Change Volumes.We are starting this season with anatomy because in head and neck oncology, anatomy is destiny. If you do not understand the drainage pathways, you cannot draw the target....2135falsefullhttps://www.spreaker.com/episode/gyn-e18-mock-oral-3-vulvar-vaginal-and-complex-recurrence-cases--6860221075ab0c2b-c73c-43eb-badc-804a568637beMon, 17 Nov 2025 11:42:32 +0000Abass ContehThis is Episode 18: *Mock Oral Boards 2 – Vulvar, Vaginal, and Complex Recurrence Cases*. This is our **final episode in the GYN series**. In the **next series, we’ll move on to Breast cancer** and build a new mock oral framework there.**Examiner:**...1594falsefullhttps://www.spreaker.com/episode/gyn-e17-mock-oral-2-cervical-and-endometrial-cancer--68602212b35ca2ba-57b1-439f-91d8-5f2940323241Mon, 17 Nov 2025 11:39:55 +0000Abass ContehToday, we're not just reviewing content; we're practicing the *performance* of the oral boards. I will act as your examiner, providing board-style prompts for eight comprehensive cases, each with a contrasting twist. When you hear the pause, answer...2207falsefullhttps://www.spreaker.com/episode/gyn-e16-brachytherapy-the-oral-boards-performance-guide--6860221416e73e56-1498-482c-8be2-ae289d5f5b39Mon, 17 Nov 2025 11:37:51 +0000Abass ContehWelcome back to Rad Onc Smart Review, GYN Series. This is Episode 16: GYN Brachytherapy — The Oral Boards Performance Guide. Today is a mock oral. I’ll ask; you answer. Then I’ll give teaching pearls. Focus on applicator selection, polished procedural...2020falsefullhttps://www.spreaker.com/episode/gyn-e14-ovarian-cancer-radonc-guide--684111174135ff4b-fef8-4f34-8843-60e9684a3619Tue, 04 Nov 2025 07:58:22 +0000Abass ContehOvarian cancer is dominated by surgery and systemic therapy. As radiation oncologists, we’re expert consultants who step in at critical junctures: to clarify staging and risk, to advise on maintenance systemic strategies that shape recurrence...1957falsefullhttps://www.spreaker.com/episode/gyn-e14-vaginal-cancer--68394006a3a01882-cbd9-4dbf-97e2-81c98852ebd0Mon, 03 Nov 2025 03:32:55 +0000Abass ContehToday we will master primary vaginal cancer from first principles to planning. We will start with epidemiology, pathophysiology, and the anatomy that dictates nodal targets. We will explain why definitive radiation is the backbone of curative therapy...2530falsefullhttps://www.spreaker.com/episode/gyn-e13-vulvar-cancer-part-2-unresectable-disease-and-a-planning-workshop--68393637cba05a42-4bcb-49bf-850b-90bb2de1ff99Mon, 03 Nov 2025 02:29:36 +0000Abass ContehLast time we built the algorithm for early vulvar cancer—who needs nodes, how sentinel mapping changes the plan, and when to radiate the vulvar bed and groins. Today we turn to the hard one: locally advanced, unresectable disease. We’ll start by...2426falsefullhttps://www.spreaker.com/episode/gyn-e12-vulvar-cancer-part-1-foundations-and-evidence-for-surgery-and-adjuvant-radiation--68329823f1a25e2f-8f9b-47c5-aca9-418522eb9ffdWed, 29 Oct 2025 09:09:49 +0000Abass ContehThis is Episode twelve: Vulvar Cancer Part one—Foundations and evidence for surgery and adjuvant radiation. Today we build from first principles—epidemiology, pathophysiology, anatomy, workup, and staging—and then walk the decision tree for surgery,...2276falsefullhttps://www.spreaker.com/episode/gyn-e11-endometrial-cancer-part-4-planning-adjuvant-pelvic-imrt-and-vaginal-cuff-hdr-brachytherapy--682956201aa7cd75-e6c2-4b45-805c-d3948dce4a98Mon, 27 Oct 2025 10:02:35 +0000Abass ContehToday is a hands-on planning workshop. We’ll simulate, contour, and plan adjuvant pelvic IMRT. Then we’ll master vaginal cuff HDR brachytherapy—from choosing the cylinder to writing the prescription and optimizing dwell times. You’ll also get two...1913falsefullhttps://www.spreaker.com/episode/gyn-e10b-endometrial-cancer-part-3-5-uterine-sarcomas-carcinosarcoma-and-medically-inoperable-endometrial-cancer--68295621167cf1b6-93b5-4736-808e-9891d5a4fb4aMon, 27 Oct 2025 09:28:35 +0000Abass ContehWelcome back to Rad Onc Smart Review, Gyn cancer series. This is a special topics episode focused on three areas that trip people up on consults and in orals: uterine sarcomas, carcinosarcoma, and how to cure medically inoperable endometrial cancer...2285falsefullhttps://www.spreaker.com/episode/gyn-e10-endometrial-cancer-part-3-advanced-stage-and-recurrent-disease--682942495f3c8b48-1d63-409f-83b1-afab0db879c5Mon, 27 Oct 2025 07:49:35 +0000Abass ContehThis is Episode ten: Endometrial Cancer, Part three — high-risk histologies and Stage three through four-A disease, plus what to do when cancer comes back.Last time we mastered adjuvant therapy for early stage. Today we zoom in on who truly benefits...2257falsefullhttps://www.spreaker.com/episode/gyn-e09-endometrial-cancer-part-2-early-stage-disease--68223192234e9676-90f4-4242-a46e-913490a915d2Tue, 21 Oct 2025 04:55:07 +0000Abass ContehLast time, we mastered modern staging and SLN mapping. Today, we answer the question you get every week in clinic: Who needs observation, who gets VBT, and who still needs pelvic EBRT? We’ll build the algorithm from GOG 99, PORTEC-1, PORTEC-2, and key...1487falsefullhttps://www.spreaker.com/episode/gyn-e08-endometrial-cancer-part-1-fundamentals--68223193ba6998ea-7927-4501-b5a4-314aa52913a4Tue, 21 Oct 2025 04:47:39 +0000Abass ContehToday we pivot from cervical to endometrial cancer, the most common gynecologic malignancy in the U.S. While many patients present early, outcomes hinge on understanding the biology and the new 2023 FIGO staging that integrates molecular data. We’ll...1905falsefullhttps://www.spreaker.com/episode/gyn-e07-cervix-cancer-part-7-new-standards-immunotherapy-induction-and-recurrence--680855797e764454-1dfc-42c5-a617-9bc02f9be999Fri, 10 Oct 2025 00:44:16 +0000Abass ContehFor two decades, concurrent cisplatin-based chemoradiation was the uncontested standard for locally advanced cervix cancer. That foundation still stands—but 2023–2024 ushered in real upgrades. Today, we’ll cover what to add (and when) for definitive...2338false57fullhttps://www.spreaker.com/episode/gyn-e06-cervix-cancer-part-6-brachytherapy-part-b-technique-and-constraints--68075499f77a139e-7be1-4a78-abd2-900cdff91ce1Thu, 09 Oct 2025 09:31:59 +0000Abass ContehIn our last episode, we established why brachytherapy is a mandatory, life-saving component of definitive cervical cancer treatment. Today, we get practical. This is a hands-on workshop covering the "how-to" of brachytherapy. We will walk through the...1761false56fullhttps://www.spreaker.com/episode/gyn-e05-cervix-cancer-part-5-brachytherapy-part-a-evidence-and-rationale--68075500860650d4-01f2-489c-b49b-c49358c40eeeThu, 09 Oct 2025 09:30:57 +0000Abass ContehIn our last episode, we mastered the modern techniques for planning pelvic external beam radiation. But for the definitive treatment of cervical cancer, EBRT is only the first half of the story. The second, non-negotiable component for achieving a...1820false55fullhttps://www.spreaker.com/episode/gyn-e04-cervix-cancer-part-4-ebrt-planning-workshop--680727947a56a5a4-d0d9-4645-9063-4976889031d1Thu, 09 Oct 2025 03:48:50 +0000Abass ContehIn our last few episodes, we’ve focused on the “why” and “when” of treating cervical cancer. Today, we shift to the “how.” This is a practical, hands-on workshop: how to simulate, contour pelvic and para-aortic nodes with modern atlases, justify IMRT...1832false54fullhttps://www.spreaker.com/episode/gyn-e03-cervix-cancer-part-3-chemort-for-locally-advanced-disease--68072793f684e8f7-c4c3-4faf-aa37-e50d69252fabThu, 09 Oct 2025 03:47:42 +0000Abass ContehToday, we are tackling one of the most significant paradigm shifts in the history of radiation oncology: the establishment of concurrent chemoradiation as the definitive standard of care for locally advanced cervical cancer. This isn't just an...1696false53fullhttps://www.spreaker.com/episode/gyn-e02-cervix-cancer-part-2-adjuvant-decisions-for-the-resected-patient--68065207837e6609-2573-4dd0-981f-149b459d3939Wed, 08 Oct 2025 15:21:52 +0000Abass ContehIn our last episode, we established the framework for managing newly diagnosed, early-stage cervical cancer. But what happens when the surgeon calls you for a post-op consult? This is one of the most common and highest-yield scenarios you will face....1518false52fullhttps://www.spreaker.com/episode/gyn-e01-cervix-cancer-part-1-staging-workup-and-early-stage-evidence--68065208ed4753bc-4210-4d94-8d48-3daaaf5581e7Wed, 08 Oct 2025 15:19:35 +0000Abass ContehWelcome back to Rad Onc Smart Review, Gyn cancer series. This is Episode 1: Cervix Cancer Part 1: Staging, Workup, and Early-Stage Evidence.Today, we're laying the foundation for our entire cervical cancer curriculum. We're going to tackle the...2236false51fullhttps://www.spreaker.com/episode/cns-e20c-mock-oral-benign-cns-tumors-srs-tts--6800116508def553-3f2c-4ab8-95d1-e5b729f84430Fri, 03 Oct 2025 14:09:11 +0000Abass ContehThis is our final episode in the C.N.S. block, Episode 20C: a comprehensive Case-Based Review of Benign C.N.S. Tumors and Stereotactic Radiosurgery cases.Over the last several episodes, we've systematically dissected the evidence that defines modern...1819falsefullhttps://www.spreaker.com/episode/cns-e20b-mock-oral-brain-metastases-spine-emergencies--679237853d77476a-9ce2-4bc4-b4f6-2e3f3d83fa77Sat, 27 Sep 2025 16:05:19 +0000Abass ContehWelcome back to Rad Onc Smart Review, C.N.S. Cancer series. Over the last several episodes, we've systematically dissected the evidence that defines modern C.N.S. oncology. We are continuing our mock oral style review of CNS oncology. I will present...2183false420fullhttps://www.spreaker.com/episode/cns-20a-hgg-lgg-mock-oral--67861137005d98cc-b5a3-4a64-a56f-7135059464aaTue, 23 Sep 2025 04:31:33 +0000Abass ContehOver the last several episodes, we've systematically dissected the evidence that defines modern CNS oncology. Today, we put that knowledge to the test. These episodes will follow a mock oral board examination. I will present comprehensive case blocks,...2752false420fullhttps://www.spreaker.com/episode/episode-19d-benign-p3d-rare-benign-rapid-review--67853729f1cfc875-0087-419f-bd6a-be111857eec9Mon, 22 Sep 2025 15:27:47 +0000Abass ContehEpisode 19D: Benign P3d: Rare Benign Rapid Review.Needs editing2067falsefullhttps://www.spreaker.com/episode/episode-19c-benign-p3c--678537302d3f6ec4-c41d-48fc-a131-30894cb2bfacMon, 22 Sep 2025 15:25:25 +0000Abass ContehThis is Episode 19c: Benign P3c: Trigeminal Neuralgia – SRS for Functional Pain.Needs editing2229falsefullhttps://www.spreaker.com/episode/episode-19b-benign-p3b-avm-part-2-srs-technique-doses-toxicity-v1--67853142aafd345e-6808-4fb1-9397-f5b8eae81363Mon, 22 Sep 2025 15:23:40 +0000Abass ContehThis is Episode 19b: Benign P3b: AVM Part 2 - SRS Technique, Doses & Toxicity. Needs editing1689false419fullhttps://www.spreaker.com/episode/cns-e19a-avm-foundations--67577887d28f6bf0-610f-4534-bb00-6d13154ade0aMon, 01 Sep 2025 06:03:20 +0000Abass ContehThis is Episode 19a, the first in our new two-part series on a fascinating and challenging benign condition: Arteriovenous Malformations, or AVMs. To build a foundational understanding of arteriovenous malformations (AVMs) by covering their biology...1916false419fullhttps://www.spreaker.com/episode/cns-e18d-non-glioma-part-2d-pituitary-adenomas-functional--67366306ad6bf2d6-1d73-454f-b369-c2ac02d42e47Thu, 14 Aug 2025 09:44:37 +0000Abass ContehIn our last episode, we mastered the management of non-functioning pituitary adenomas, where the primary goal of radiation is long-term tumor control. Today, we tackle the more complex world of functional, or secreting, pituitary adenomas. Here, the...1490false418fullhttps://www.spreaker.com/episode/cns-18c-non-glioma-part-2c-pituitary-adenomas-non-functioning--67366307a76b481f-faac-4ffe-96d3-8a5dd06f254bThu, 14 Aug 2025 09:43:25 +0000Abass ContehIn our last two episodes, we mastered the management of vestibular schwannomas. Today, we shift our focus to another common sellar region tumor: the pituitary adenoma. While often discovered incidentally, these tumors can cause significant morbidity...1325false418fullhttps://www.spreaker.com/episode/cns-e18b-non-glioma-part-2b-vestibular-schwannoma-radiation-planning--673663102c8946ce-4f7e-428d-b4ac-2e9d4b8645caThu, 14 Aug 2025 09:42:07 +0000Abass ContehIn our last episode, we established the foundational framework for managing vestibular schwannomas. We worked up our patient, a 55-year-old man with a Koos Grade II tumor and serviceable hearing, and after reviewing the options, decided that...2558false418fullhttps://www.spreaker.com/episode/cns-e18a-non-glioma-part-2a-vestibular-schwannoma-basics--67366309a55c8009-46ca-4cb8-a746-5424b90eb139Thu, 14 Aug 2025 09:40:24 +0000Abass ContehToday we're tackling one of the most common non-malignant brain tumors you will treat: the vestibular schwannoma, also known as an acoustic neuroma. While histologically benign, these tumors can cause significant, life-altering morbidity by affecting...1838false418fullhttps://www.spreaker.com/episode/cns-17b-meningioma-part-2-version-1--67244168f62d0492-29df-4386-8203-7f58c7f67b92Mon, 04 Aug 2025 09:42:24 +0000Abass ContehThis is Episode 17b: Non-Glioma Part 2: Atypical & Anaplastic Meningiomas & Future Directions.In Episode 17a, we built the essential foundation for understanding meningiomas, covering their epidemiology, detailed WHO grading, and the...1699falsefullhttps://www.spreaker.com/episode/cns-e17a-version-1--67244170ca454820-5023-464d-bdf0-195cdbf077b3Mon, 04 Aug 2025 09:41:08 +0000Abass ContehThis is Episode 17a: Non-Glioma Part 1: Meningioma Foundations & Grade I Management. While gliomas often take the spotlight, the single most common primary intracranial tumor you will encounter is the meningioma. But don't let its often-benign...2765falsefullhttps://www.spreaker.com/episode/cns-e16-spine-sbrt-technique-re-irradiation-workshop--6723423221946957-1dac-4a75-a319-0581b27f1f71Sun, 03 Aug 2025 02:43:43 +0000Abass ContehIn our last episode, we laid the complete foundation for managing spinal metastases. Today, we transition from the broad strokes of conventional palliation to the high-precision, high-impact world of Stereotactic Body Radiation Therapy, or SBRT. This...2118falsefullhttps://www.spreaker.com/episode/cns-e15b-spine-mets-part-2-stability-cord-compression-management--67234231f86732cc-d6c5-49d3-b8c6-9277c48f8ab0Sun, 03 Aug 2025 02:41:59 +0000Abass ContehIn Episode 15a, we covered the comprehensive workup for a patient with suspected spinal metastases, from distinguishing pain types to detailed imaging interpretation and initial supportive care. Today, we move to the definitive decisions. We will...1784falsefullhttps://www.spreaker.com/episode/cns-e15a-spine-mets-part-1-anatomy-initial-workup--67234234930e02c6-6fb5-42c8-b51b-5379da9c971aSun, 03 Aug 2025 02:36:31 +0000Abass ContehThis is Episode 15a, the first in our new two-part foundational series on Spinal Metastases. Today's episode is titled: "Spine Mets Part 1: Anatomy & Initial Workup."Metastatic disease to the spine is one of the most common and challenging...2480falsefullhttps://www.spreaker.com/episode/g-i-e22-case-based-review-lower-gi--67148540b202f552-8729-4b70-b5d4-12752a1f6876Mon, 28 Jul 2025 03:14:34 +0000Abass ContehThis is our mock oral boards for lower GI malignancies. I will present two comprehensive rectal cancer cases, walking you through each one from initial presentation all the way through treatment and follow-up. For each section, I want you to pause and...2543false322fullhttps://www.spreaker.com/episode/g-i-e21-case-based-review-upper-gi-v1--67200109b5419d76-2bf2-4f59-844e-8e320d71a5d8Sun, 27 Jul 2025 15:20:00 +0000Abass ContehOver the last several episodes, we've systematically broken down the evidence that defines modern GI oncology. Today, we put that knowledge to the test. This episode is a mock oral board examination. I will present five comprehensive case blocks,...2606false322fullhttps://www.spreaker.com/episode/cns-e14-brain-metastases-case-based-review-and-management-strategies--66970560df3101a2-8a3b-433d-acd5-5b20eab05cdbMon, 14 Jul 2025 04:26:45 +0000Abass ContehThis episode is a mock oral boards session. I will present three distinct, challenging clinical scenarios. For each case, we will walk through the entire management process, from initial presentation all the way through treatment and follow-up, to...1316false414fullhttps://www.spreaker.com/episode/cns-e13-brain-mets-5-srs-meets-io-targeted-therapy-a-sequencing-guide--66970559d03bb407-343b-4ef0-9cc2-9d776a47040fMon, 14 Jul 2025 04:25:33 +0000Abass ContehOver the past decade, the landscape of systemic therapy has been transformed by the arrival of immunotherapy and highly effective targeted agents. Many of these drugs have significant intracranial activity, creating a new and complex challenge for the...1019false413fullhttps://www.spreaker.com/episode/cns-e12-brain-mets-4-5-mets-large-lesions-radiation-necrosis--66970237a50b5fd7-f28c-4d11-bed9-5dd78d68512cMon, 14 Jul 2025 04:23:14 +0000Abass ContehToday, we address the frontiers of SRS. First, we'll ask: can we treat more than four metastases? Second, how do we safely and effectively treat large metastases that are too big for a single high dose of radiation? And finally, we will tackle the...1082false412fullhttps://www.spreaker.com/episode/cns-e11-brain-mets-part-3-a-post-op-srs-workshop--66970236f31cd741-cfb6-4a05-ad5b-35833a32a489Mon, 14 Jul 2025 04:22:14 +0000Abass ContehToday, we will conduct a practical workshop on postoperative stereotactic radiosurgery. We'll dissect the two landmark trials that define this practice, learn how to properly delineate a post-operative target volume, and discuss the dreaded...1025false411fullhttps://www.spreaker.com/episode/cns-e10-brain-mets-part-2-the-srs-revolution-when-to-omit-wbrt--66970239f5b1d131-4f66-4e31-afee-9baade5e5257Mon, 14 Jul 2025 04:21:28 +0000Abass ContehIn our last episode, we laid the groundwork for managing brain metastases. Today, we tackle one of the most significant paradigm shifts in modern radiation oncology: the move away from routine whole-brain radiotherapy for patients with a limited...1231false410fullhttps://www.spreaker.com/episode/cns-e09-brain-metastases-prognosis-and-wbrt-toolkit--66970238c24e3ca5-7d30-484f-b551-09a534d7b88dMon, 14 Jul 2025 04:20:34 +0000Abass ContehBrain metastases are the most common intracranial tumor in adults, and their management has undergone a complete revolution. Before we can treat, we must be able to prognosticate and have a firm grasp of the foundational principles. Today, we will...1141false49fullhttps://www.spreaker.com/episode/cns-e08-lgg-part-3-treatment-planning-case-based-review--6696717552fbcd09-4432-4eb8-84b0-1cae3a75755dSun, 13 Jul 2025 17:51:02 +0000Abass ContehThis is Episode 8: Low-Grade Glioma Part 3: Treatment Planning & Case-Based Review. Over the last two episodes, we've built the complete evidence-based framework for managing WHO Grade II gliomas. We've learned how to risk-stratify patients, when...1514false48fullhttps://www.spreaker.com/episode/cns-e07-low-grade-glioma-evidence-for-treatment-and-idh-inhibitors--66961259e4d2ad35-2d0c-450d-a805-199020ed497aSun, 13 Jul 2025 04:56:07 +0000Abass ContehThis is Episode 7: Low-Grade Glioma Part 2: Evidence for Chemo, Dose, and IDH Inhibitors.In our last episode, we established the framework for managing Grade II gliomas, answering the crucial question of when to treat. Today, we address the next...929false47fullhttps://www.spreaker.com/episode/cns-e06-low-grade-gliomas-foundations-risk-and-timing--669612589cdcc888-d5bf-4958-ac5c-1ee9c67578f6Sun, 13 Jul 2025 04:54:58 +0000Abass ContehThis is Episode 6, and we are kicking off our new mini-series on Low-Grade Gliomas. Today's episode is titled: "LGG P1: Foundations, Risk Stratification & The Timing Debate."For years, the management of WHO Grade II gliomas has been one of the...888false46fullhttps://www.spreaker.com/episode/cns-e05-hgg-treatment-planning-workshop--6687792502c7a38d-e086-47b7-af4f-862e3d95e750Sun, 06 Jul 2025 20:49:22 +0000Abass ContehIn our first four episodes, we've established the "what" and the "why" of high-grade glioma management. Today, we get practical and move to the "how." Treatment planning is a core competency for any radiation oncologist, and for high-grade gliomas,...1510false45fullhttps://www.spreaker.com/episode/cns-04-hgg-special-cases-and-advanced-treatments--66877924c9a42870-f907-4648-a3a8-c603806428e7Sun, 06 Jul 2025 20:46:02 +0000Abass ContehIn our first three episodes, we mastered the standard approach for a "Stupp-eligible" patient with glioblastoma. But as you know, many of our patients do not fit this mold. They are older, have a lower performance status, or present with the...1527false44fullhttps://www.spreaker.com/episode/cns-e03-gbm-foundations-and-the-stupp-protocol--668779267a3d6e20-495b-452b-8a26-1401beb66d82Sun, 06 Jul 2025 20:43:43 +0000Abass ContehIn our first two episodes, we built the modern diagnostic framework for high-grade gliomas, focusing on anaplastic oligodendrogliomas and astrocytomas. Today, we turn our attention to the most common and most formidable of these tumors: glioblastoma,...1238false43fullhttps://www.spreaker.com/episode/cns-e02-high-grade-glioma-part-2-anaplastic-astrocytoma-and-the-rise-of-molecular-grade-4--66877927]]>8de478f8-fae6-48a4-b085-1c5c8073a855Sun, 06 Jul 2025 20:41:55 +0000Abass ContehIn our last episode, we established the modern molecular framework for diagnosing high-grade gliomas and detailed the management of anaplastic oligodendroglioma. Today, we explore the other side of that coin. We will master the management of...]]>1873false42fullhttps://www.spreaker.com/episode/cns-e01-modern-glioma-classification-and-anaplastic-oligodendroglioma--66877928e2b9def3-6f6e-4bf9-92b8-a5d198e99ff5Sun, 06 Jul 2025 20:39:05 +0000Abass ContehWelcome back to Rad Onc Smart Review, CNS Edition.T his is Episode 1 of our new series on CNS oncology, titled: Modern Classification & Anaplastic Oligodendroglioma Evidence. For decades, we treated high-grade gliomas based on what a pathologist...1317false41fullhttps://www.spreaker.com/episode/g-i-e20b-anal-cancer-part-4-guidelines-toxicity-follow-up-future-directions--670537160bf4fd64-944b-4847-b7ea-fd5126ff64f9Sun, 29 Jun 2025 23:50:00 +0000Abass ContehThis is Episode 20B: Anal Cancer Part 4: Guidelines, Toxicity, Follow-Up & Future Directions. Over the last three episodes, we've built a comprehensive understanding of anal cancer, from its foundational anatomy and staging, to the landmark trials...2112false320fullhttps://www.spreaker.com/episode/g-i-e20-anal-cancer-part-2-imrt-planning-and-special-populations--6679986827f47670-1c8d-4376-9735-25adf4d7e33aSun, 29 Jun 2025 23:49:07 +0000Abass ContehIn our last episode, we established the foundations of anal cancer therapy, proving that definitive chemoradiation with 5-FU and Mitomycin-C is the organ-preserving standard of care. But while this approach is highly effective, it is also notoriously...1259false320fullhttps://www.spreaker.com/episode/g-i-e19b-anal-cancer-part-2-modern-ccrt-chemo-dose-timing--67053717b22a8207-9385-4174-af52-64c8f7ae3ca5Sun, 29 Jun 2025 23:42:00 +0000Abass ContehIn our last episode, we laid the foundation for anal cancer management, establishing definitive concurrent chemoradiation as the sphincter-sparing standard of care, thanks to the pioneering work of Dr. Nigro and the pivotal ACT I and EORTC trials. We...2269false319fullhttps://www.spreaker.com/episode/g-i-e19-anal-cancer-part-1-anatomy-foundations-and-modern-ccrt--6679986947aeb6d4-8603-4117-bfb8-6d350a42e83aSun, 29 Jun 2025 23:41:02 +0000Abass ContehWe've arrived at our final primary site in the lower GI tract: anal cancer. In many ways, this disease is the ultimate success story for radiation oncology. It is one of the few solid tumors where we have moved from a paradigm of radical, mutilating...1516falsefullhttps://www.spreaker.com/episode/g-i-e18a-rectal-cancer-part-4a-advanced-recurrent-disease-management--670508776caafef4-b225-4c45-80ca-974c33ba22ebSun, 29 Jun 2025 23:41:00 +0000Abass ContehToday, we shift our focus to managing advanced and recurrent rectal cancer. We will outline the systemic therapy options for metastatic colorectal cancer, including the roles of specific chemotherapies and biologics based on molecular markers. We'll...1894false318fullhttps://www.spreaker.com/episode/g-i-e18b-rectal-cancer-part-4b-treatment-planning-contouring-workshop--67050876da03933d-7fb6-4b85-98eb-be9e0edf2683Sun, 29 Jun 2025 23:41:00 +0000Abass ContehToday, we're stepping into the treatment planning suite. We'll walk through the entire process, from patient education and simulation setup to the meticulous art of target volume delineation and the critical science of dose selection and OAR...2307false318fullhttps://www.spreaker.com/episode/g-i-e18c-rectal-cancer-part-4c-toxicity-follow-up-survivorship--6705087589a9b389-7378-4a72-9100-2d9c4348e87eSun, 29 Jun 2025 23:41:00 +0000Abass ContehToday, in our final episode on rectal cancer, we'll equip you with practical strategies for managing acute on-treatment toxicities. We'll then delineate evidence-based follow-up schedules, contrasting operative and non-operative approaches. Finally,...1527false318fullhttps://www.spreaker.com/episode/g-i-e18-rectal-cancer-part-4-planning-re-irradiation-final-review--66799872442de84f-ccf6-4c5c-b07b-fbcb1fd7fe30Sun, 29 Jun 2025 23:36:49 +0000Abass ContehOver the last three episodes, we have constructed the entire modern framework for rectal cancer management. We’ve established when to treat, how to treat, and who to treat with advanced strategies like TNT and immunotherapy. Today, we bring it all to...1265false18fullhttps://www.spreaker.com/episode/g-i-e17c-rectal-cancer-part-3c-omission-of-rt-the-prospect-trial-deep-dive--670508786d23c612-12b3-4f99-8ca7-a0941a3bd0b2Sun, 29 Jun 2025 23:35:00 +0000Abass ContehIn our previous discussions, we've firmly established the role of neoadjuvant radiation therapy for locally advanced rectal cancer. However, radiation, while life-saving, comes with its own set of acute and late toxicities—from sexual dysfunction and...1808false317fullhttps://www.spreaker.com/episode/g-i-e17b-rectal-cancer-part-3b-organ-preservation-and-dmmr-management--67049521a4c81d2f-8ad0-4536-a64c-1b3e91daebb7Sun, 29 Jun 2025 23:33:00 +0000Abass ContehIn our last episode, we explored Total Neoadjuvant Therapy, or TNT, which has revolutionized the management of high-risk locally advanced rectal cancer by increasing pathologic complete response, or pCR, rates and improving distant control. These...2014falsefullhttps://www.spreaker.com/episode/g-i-e17-rectal-cancer-part-3-the-tnt-revolution-dmmr-management--667998702aa76ff4-ef54-4e9f-b25b-4505e956a203Sun, 29 Jun 2025 23:32:26 +0000Abass ContehIn our last episode, we established the foundational principles of neoadjuvant radiation, proving that giving RT before surgery is superior and comparing the short-course and long-course approaches. That framework is perfect for standard-risk disease....1306false317fullhttps://www.spreaker.com/episode/g-i-e16-rectal-cancer-part-2-neoadjuvant-foundations--66799871d035dc6f-fc73-48c7-8d2d-8751dcaa825eSun, 29 Jun 2025 23:29:38 +0000Abass ContehIn our last episode, we established the fundamental clinical landscape of rectal cancer—the anatomy, the critical role of MRI in staging, and the surgical revolution of Total Mesorectal Excision. We learned that with high-quality TME, surgeons could...1955false316fullhttps://www.spreaker.com/episode/g-i-e15-rectal-cancer-part-1-anatomy-staging-and-the-tme-revolution--667998730f856c4e-eaba-44b2-a527-cbb9c63ebf34Sun, 29 Jun 2025 23:27:36 +0000Abass ContehIf there is one disease site that perfectly illustrates the power of multidisciplinary, evidence-based cancer care, it’s rectal cancer. The evolution of its treatment is a masterclass in how surgery, radiation, and chemotherapy can be integrated to...1826false315fullhttps://www.spreaker.com/episode/g-i-e14-liver-p3-biliary-cancers-metastasis-management--6679287363fbea35-c780-4135-92fb-5af7916a01edSun, 29 Jun 2025 07:32:24 +0000Abass ContehToday, we conclude our liver mini-series by tackling these crucial topics.F irst, we’ll cover the evidence-based management for biliary tract cancers—including gallbladder cancer and cholangiocarcinoma—with a focus on the patterns of failure that...1326false314fullhttps://www.spreaker.com/episode/g-i-e13-hcc-part-2-sbrt-workshop-doses-data-no-fly-zones--6679287222b3b7bc-0cf5-4285-a6a5-a1e8356c6245Sun, 29 Jun 2025 07:31:11 +0000Abass ContehToday, we conduct our SBRT masterclass for HCC. We will make the definitive case for SBRT over other local therapies by citing the key comparative data. We'll detail the evidence for treating high-risk disease like portal vein thrombosis and walk...1997false313fullhttps://www.spreaker.com/episode/g-i-e12-hcc-part-1-the-hcc-toolkit-staging-ir-and-systemic-therapy--6679287149411893-b762-4011-9027-966b56c557e5Sun, 29 Jun 2025 07:29:47 +0000Abass ContehWelcome back to Rad Onc Smart Review, GI Series.T his is Episode 12: HCC Part 1: The HCC Toolkit – Staging, IR, and Systemic Therapy . Hepatocellular carcinoma, or HCC, is a unique beast in oncology. Unlike most cancers where our focus is solely on...1736false312fullhttps://www.spreaker.com/episode/g-i-e11-pancreas-part-4-guideline-planning-case-based-review--667824819e27841d-c4ae-442a-9219-cd5c418e5dadSat, 28 Jun 2025 02:11:04 +0000Abass ContehOver the last three episodes, we've journeyed through the complex evidence for pancreatic cancer. We’ve dissected the adjuvant debate, explored the neoadjuvant revolution, and held a masterclass on SBRT. Now, it’s time to put it all together. This is...1975false311fullhttps://www.spreaker.com/episode/g-i-e10-pancreas-part-3-lapc-sbrt-masterclass--6678226652b1299a-32f3-4ff2-8352-e6d349eaeb8fSat, 28 Jun 2025 01:17:12 +0000Abass ContehIn our last two episodes, we focused on patients with resectable or borderline resectable pancreatic cancer—those for whom surgery is the ultimate goal. Today, we turn to a different, but equally challenging scenario: the patient with locally...1248false310fullhttps://www.spreaker.com/episode/g-i-e09-pancreas-part-2-the-neoadjuvant-revolution-for-resectable-borderline-resectable-pancreatic-cancer--66782267297e8af8-6d43-461b-98fd-c4e5d70d6b9eSat, 28 Jun 2025 01:10:12 +0000Abass ContehWelcome back to Rad Onc Smart Review, GI Series. In our last episode, we wrestled with the difficult data for adjuvant therapy, where even after a grueling Whipple procedure, the prognosis remains guarded. This reality has fueled one of the most...2376false39fullhttps://www.spreaker.com/episode/g-i-e08-pancreas-part-1-the-adjuvant-setting-the-great-rt-debate--6678227057d309f5-c7ef-4c3e-bf80-dacdd5eb1d02Sat, 28 Jun 2025 01:05:16 +0000Abass ContehWelcome back to Rad Onc Smart Review, GI Series. Pancreatic cancer carries one of the most sobering prognoses in oncology. For the small fraction of patients who present with resectable disease, surgery offers the only hope for a cure. But even after...1974false38fullhttps://www.spreaker.com/episode/g-i-e07-gastric-cancer-part-2-adjuvant-rt-targeted-therapy-planning--66782271de3ecab3-f0b8-4bd1-b563-0aa2bb892f56Sat, 28 Jun 2025 01:02:40 +0000Abass ContehIn our last episode, we established that for resectable gastric cancer, high-quality D2 surgery and effective perioperative chemotherapy with FLOT is the modern standard of care. But that raises a critical question for us as radiation oncologists:...1097false37fullhttps://www.spreaker.com/episode/g-i-e06-gastric-cancer-part-1-covering-surgery-and-perioperative-chemotherapy--66782269bb1bbb3d-d2ee-4a1c-ad0c-4c2d1c49c2e0Sat, 28 Jun 2025 00:59:04 +0000Abass ContehWelcome back to Rad Onc Smart Review, where we break down the clinical decisions that matter most in radiation oncology. This is Episode six: Gastric Cancer Part one, covering Surgery and Perioperative Chemotherapy.Gastric cancer remains a major...1983false36fullhttps://www.spreaker.com/episode/g-i-e05-esophagus-part-4-nom-advanced-disease-treatment-planning--66782273aea56246-090b-4dd4-8674-adeae58f9c15Sat, 28 Jun 2025 00:57:25 +0000Abass ContehThis is Episode 05: Esophagus Part 4: NOM, Advanced Disease & Treatment Planning.This is our capstone episode on esophageal cancer. We’ve covered the fundamentals, the landmark trials, and the modern debates. Today, we bring it all together. We’ll...2077false35fullhttps://www.spreaker.com/episode/g-i-e04-esophagus-part-3-the-dose-escalation-adjuvant-io--66782272295b04dc-cda0-421d-8981-9e267eada19fSat, 28 Jun 2025 00:55:04 +0000Abass ContehThis is Episode 04: Esophagus Part 3: The Dose Escalation & Adjuvant IO Debates.In our last episode, we laid the foundation with the landmark trials establishing neoadjuvant and definitive chemoradiation. But a key principle in oncology is to...1393false34fullhttps://www.spreaker.com/episode/g-i-e03-esophagus-part-2-neoadjuvant-definitive-ccrt--6678227494d4a5b8-b286-4307-a5a4-eeeb36486007Sat, 28 Jun 2025 00:49:15 +0000Abass ContehThis is Episode 03: Esophagus Part 2: Neoadjuvant & Definitive CCRT.In our last episode, we laid the groundwork for esophageal cancer management. Now, we move to the heart of the matter: how we treat locally advanced disease. This episode is all...1481false33fullhttps://www.spreaker.com/episode/g-i-e02-esophagus-part-1-anatomy-staging-surgical-options--66782276f02f83f1-006d-464a-9911-31d98be9405eSat, 28 Jun 2025 00:41:24 +0000Abass ContehThis is Episode 02: Esophagus Part 1: Anatomy, Staging & Surgical Options.Getting the fundamentals right in esophageal cancer is everything. It's a disease where anatomy dictates treatment fields, staging dictates modality, and surgical approach...1766false32fullhttps://www.spreaker.com/episode/g-i-e01-principles-re-rt-toxicity-contouring-rare-sites--6678227543479732-2660-44a3-826d-363579027e10Sat, 28 Jun 2025 00:38:49 +0000Abass ContehWelcome back to Rad Onc Smart Review, G.I. Oncology Edition. This is Episode 01: GI Principles: Re-RT, Toxicity, & Contouring Rare Sites.Before we dive deep into specific GI malignancies, we’re going to build a strong foundation. This episode...1642false31fullhttps://www.spreaker.com/episode/radbio-e39c-radbio-calculations-1-quantifying-cell-survival--666793824f70586e-0d3b-41e7-856b-3f9e9a329a93Sat, 21 Jun 2025 18:54:36 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 39C in our special series on Radiobiology Calculations. Today, we’re tackling the mathematics that underpins the very foundation of modern radiation therapy: fractionation. Why do we give many...2371false239fullhttps://www.spreaker.com/episode/radbio-e39b-radbio-calculations-2-tumor-control-kinetics--666786462ae97fed-d8da-488a-972e-8e26ad74defbSat, 21 Jun 2025 18:17:41 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 39B, the second installment of our special series on Radiobiology Calculations. Today, our focus is on Tumor Control & Kinetics. In our last episode, we mastered the calculations for cell...1413false239fullhttps://www.spreaker.com/episode/radbio-e39a-radbio-calculations-1-quantifying-cell-survival--66678647a3c34385-a3a7-406a-a46b-86b6fec8feb5Sat, 21 Jun 2025 18:00:39 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 39A, and the first in our special series on Radiobiology Calculations. In this episode, Calculations 1: Quantifying Cell Survival, we're moving beyond concepts and getting our hands dirty with the...2914false239fullhttps://www.spreaker.com/episode/radphysics-e18c-radonc-board-exam-physics-essential-review--66512412af537974-5b22-4b53-8394-9093f2e49645Wed, 11 Jun 2025 17:26:51 +0000Abass ContehToday, we're doing a rapid-fire, high-yield review of the absolute must-know concepts, formulas, and numbers for your board exams. We'll move quickly through seven key domains, from fundamental physics to advanced modalities and safety guidelines....2364false118fullhttps://www.spreaker.com/episode/radphysics-e18b-radiation-physics-overview-part-2--6661805924c0390f-dd41-4345-81bb-7ab3da6dbc03Wed, 11 Jun 2025 05:30:00 +0000Abass ContehWelcome back to our deep dive on the core principles of radiation physics. This is Part B of our comprehensive physics review. In Part A, we built the foundation, exploring everything from the atom and radioactive decay to the complex machines that...3624false118fullhttps://www.spreaker.com/episode/radphysics-e18b-physics-overview--6650262079bf05bd-2420-4538-bd30-8c3834d4336bWed, 11 Jun 2025 02:22:48 +0000Abass ContehPart 2 of physics overview3774false118fullhttps://www.spreaker.com/episode/radphysics-e18-physics-overview--6649863795cd9de8-fb4b-4a4c-a4b4-b9986652abddTue, 10 Jun 2025 18:53:15 +0000Abass ContehPhysics overview touching a little of every topic...work in progress.6823false118fullhttps://www.spreaker.com/episode/radphysics-e17d-lungs-seeds-and-safety-shields--66458841ac82c255-dc3d-4b1c-b9d1-30f742e9163fSun, 08 Jun 2025 05:48:57 +0000Abass ContehThis is our final episode focused purely on calculations! We've journeyed from basic decay to complex Monitor Unit calculations. Today, we hit the advanced scenarios: What happens when the beam hits lung or bone? How do we compare radically different...3239false117fullhttps://www.spreaker.com/episode/radphysics-e17c-dose-divers-and-electron-escapades--664560432427e45e-f7af-4365-a909-8ecbbc17e6c7Sun, 08 Jun 2025 03:01:55 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – Calculation Toolkit Episode 17C: Dose Divers and Electron Escapades. Last time, we calibrated our detectors and nailed Monitor Unit calculations for standard setups. Now, we follow the dose after it...2996false117fullhttps://www.spreaker.com/episode/radphysics-e17b-dosimetry-detectives-and-chamber-charades--66456039e30a6640-69bd-49f6-88e0-ec073b222b1eSun, 08 Jun 2025 03:00:50 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – Episode 17 part B: Dosimetry Detectives and Chamber Charades. Last time, we tackled the ticking clocks of decay and permanent implants. Today, we put on our detective hats to investigate how we...2208false117fullhttps://www.spreaker.com/episode/radphysics-e17a-calculations-1-half-lives-and-seed-sleuths--66456049365156f7-2283-4d30-b2fb-6a43ec15b7d7Sun, 08 Jun 2025 02:58:55 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – the targeted prep for your radiation oncology boards! I’m your guide, diving deep into the calculations that matter. This is Episode 17a of our Calculation Toolkit series, titled Radiation Oncology...1945false117fullhttps://www.spreaker.com/episode/radphysics-e16c-pet-ultrasound-physics-for-radonc--66447769cdc61978-37d7-4267-95ec-0135affcbc6aSat, 07 Jun 2025 20:11:11 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series for our concluding episode! In P16b, we explored the crucial planning modalities of CT and MRI. Today, in Episode P16c: PET & Ultrasound Physics for RadOnc, we round out our imaging tour by...2118false116fullhttps://www.spreaker.com/episode/radphysics-e16b-ct-mri-physics-for-radonc--664477680c488a83-b7b0-404b-a086-e815ae7e48f1Sat, 07 Jun 2025 20:09:54 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P16a, we covered the crucial principles of radiation protection and the regulations governing our field. Now, in Episode P16b: CT & MRI Physics for RadOnc, we dive into the physics behind...3065false116fullhttps://www.spreaker.com/episode/radphysics-e16a-radiation-protection-regulations--6644777063685962-8d10-4dd3-a242-1c4fd42cd34fSat, 07 Jun 2025 19:38:56 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've explored how radiation is produced, how it interacts, how we measure it, plan treatments, and ensure quality. Now, we circle back to a fundamental responsibility: radiation safety. In...3264false116fullhttps://www.spreaker.com/episode/radphysics-e15c-brachytherapy-qa-safety-regulations--664331650b2eb889-4394-472d-a2f0-d316bfddb37aSat, 07 Jun 2025 04:36:42 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In E15a, we covered brachytherapy sources and TG-43 dose calculations. In P15b, we looked at clinical applications and planning systems. Now, in our final brachytherapy episode, P15c:...3165false115fullhttps://www.spreaker.com/episode/radphysics-e15b-brachytherapy-applications-systems-planning-concepts--66433166d9cb8cac-c014-4bf5-b437-03b6f125c25dSat, 07 Jun 2025 04:33:54 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P15a, we laid the groundwork for brachytherapy, focusing on the radioactive sources, how their strength is quantified using Air Kerma Strength (SK), and the details of the TG-43 dose...3290false115fullhttps://www.spreaker.com/episode/radphysics-e15a-brachytherapy-physics-sources-strength-dose-calculation--66433168eccf4265-50e2-4776-a77d-637885df0613Sat, 07 Jun 2025 04:32:48 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've thoroughly covered external beam therapy. Now, we're shifting gears dramatically to explore treatments where the radiation source is placed inside or very close to the target. In Episode...3625false115fullhttps://www.spreaker.com/episode/radphysics-e14b-proton-therapy-physics-planning--664249387e89fb52-3d42-4edb-8d74-2c583d0616f9Fri, 06 Jun 2025 19:05:14 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In 14a, we explored the world of electron beams. Now, in Episode 14b: Proton Therapy Physics & Planning, we turn to the heavyweights: protons. Protons offer a unique dose deposition pattern,...2924false114fullhttps://www.spreaker.com/episode/radphysics-e14a-electron-beam-physics-planning--6642493743970f6a-6e86-4f2a-abaf-155f300fdd0eFri, 06 Jun 2025 18:37:16 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! After exploring advanced photon techniques like IMRT, VMAT, and SRS/SBRT, we're now switching particle types. In Episode P14a: Electron Beam Physics & Planning, we focus entirely on the...3345false114fullhttps://www.spreaker.com/episode/radphysics-e13b-stereotactic-techniques-srs-sbrt-physics-delivery--664249441582a35e-d193-4f5d-9aff-f25070d28e44Fri, 06 Jun 2025 18:27:16 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P13a, we covered the principles of IMRT and VMAT for delivering conformal dose distributions. Today, in Episode P13b: Stereotactic Techniques, we push the boundaries of precision even further....3751false113fullhttps://www.spreaker.com/episode/radphysics-e13a-intensity-modulated-therapy-imrt-vmat-principles-qa--66414285d4ad61c2-cab1-49c1-810b-f456a9682c76Fri, 06 Jun 2025 00:01:12 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P12b, we defined the crucial ICRU target volumes (GTV, CTV, PTV). Now, how do we deliver dose that conforms tightly to those volumes, especially when they're complex shapes wrapped around...2014false113fullhttps://www.spreaker.com/episode/radphysics-e12b-treatment-planning-volumes-concepts--664128632c8d2198-2e41-4b07-881c-644a51ae2620Thu, 05 Jun 2025 20:24:20 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In E12a, we mastered the formulas for calculating Monitor Units to deliver a specific dose to a point. But radiation therapy treats volumes. How do we define these volumes precisely, accounting...2778false112fullhttps://www.spreaker.com/episode/radphysics-e12a-mu-calculations-ssd-sad-formulas--66387342ff0cf79c-3bfa-4b5d-baf5-1c87679891d6Tue, 03 Jun 2025 21:03:56 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've gathered all the ingredients: Calibrated Output (CAL), Output Factors (Sc,p), Beam Modifiers (WF, TF), and Patient Attenuation Factors (PDD, TMR). Now, in Episode P12a: MU Calculations (SSD...2833false112fullhttps://www.spreaker.com/episode/radphysics-e11-mu-calculation-components--663873412dc74e8d-18d8-4a74-bf97-5aa1aaee9453Tue, 03 Jun 2025 20:24:12 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In Episode P10, we defined the key descriptors of dose distribution – PDD for SSD setups and TMR for SAD setups – which tell us how dose varies with depth, energy, and field size relative to a...2097false111fullhttps://www.spreaker.com/episode/radphysics-e10-ebrt-dose-descriptors--663866779bd27c1d-cef9-4a9a-b4ed-c396b6319dbcTue, 03 Jun 2025 19:32:23 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P9, we mastered the art of calibration using TG-51, linking machine output (MU) to absolute dose under reference conditions. But patients aren't water phantoms treated at 10 cm depth with a...2241false110fullhttps://www.spreaker.com/episode/radphysics-e9-tg-51-calibration-essentials--66377595f2accd5e-8f07-4716-9215-a12eeeaa50bbTue, 03 Jun 2025 02:26:48 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P8, we stressed the importance of Quality Assurance – making sure our LINACs work correctly. But QA relies on having an accurate baseline measurement of the machine's output. How do we...2830false19fullhttps://www.spreaker.com/episode/radphysics-e08-beam-quality-characteristics--663759813cfe3024-d7af-4ed4-88ff-a4977b4df7ceMon, 02 Jun 2025 22:40:13 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! After diving deep into dosimetry detectors and concepts in P7a and P7b, we now turn our focus in Episode P8a to the Beam Quality & Characteristics. How do we objectively describe the...2707false18fullhttps://www.spreaker.com/episode/radphysics-e07b-bragg-gray-theory-the-dosimetry-toolkit--66374074b85d1170-b1ee-4452-8664-ae27309b0f8cMon, 02 Jun 2025 19:32:27 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P7a, we established the concept of Exposure, detailed the ionization chamber, and learned how the f-factor converts exposure-in-air to dose-in-medium. But how can we be sure that measuring...2380false17fullhttps://www.spreaker.com/episode/radphysics-e06-photon-interactions-basic-dose-concepts--6636295955523ba9-bb80-40d1-a1e6-ec3de1720ed5Mon, 02 Jun 2025 04:17:00 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P5, we explored the powerful machines, especially LINACs, that generate high-energy photon (X-ray) beams. Now that we have these beams, what happens when they actually hit the patient? In...1539false16fullhttps://www.spreaker.com/episode/radphysics-e05-high-energy-treatment-machines--663629607463d845-4693-48e7-a7a7-ca1b89c2938aMon, 02 Jun 2025 04:14:51 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! Last episode, P4, we learned how kV X-rays are produced in tubes. Today, we're powering up significantly in Episode P5: High Energy Treatment Machines. We'll explore the historical Cobalt-60...1371false15fullhttps://www.spreaker.com/episode/physics-e04-kv-x-ray-production--66353561ca42cb9d-149a-4aee-aefc-da4f188c5f0fSun, 01 Jun 2025 01:21:00 +0000Abass ContehWelcome back to RadOnc Smart Review, Physics Series! In P3, we saw how charged particles like electrons lose energy interacting with matter. Today, in Episode P4: kV X-ray Production, we harness those interactions! We'll focus specifically on how we...2001false14fullhttps://www.spreaker.com/episode/radphysics-e07a-measuring-dose-exposure-ion-chambers-the-f-factor--663531878c88e4c2-9d4a-4455-9c4b-012ded9f0c88Sat, 31 May 2025 22:31:22 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P6, we saw how photons interact – PE, Compton, Pair Production. Now we need to quantify the result: dose. In Episode P7a: Measuring Dose - Exposure, Ion Chambers & The f-factor, we'll...2342false17fullhttps://www.spreaker.com/episode/radphysics-e03-particulate-interactions--663462837eef0911-3e3e-458c-b87b-c47bba5e8379Fri, 30 May 2025 23:59:24 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P2, we explored radioactive decay, where unstable nuclei emit particles like alphas and betas. Now, in Episode P3: Particulate Interactions, we'll follow those particles – and others like...1350false13fullhttps://www.spreaker.com/episode/radphysics-e02-radioactive-decay--66346282db415e0b-5de9-4da9-b884-f377f3ce56b3Fri, 30 May 2025 23:53:53 +0000Abass ContehWelcome back to RadOnc Smart Review, Physics Series! Last time, in P1, we looked at the atom's structure and what happens when electrons get shuffled around. Today, in Episode 2: Radioactive Decay, we're focusing on the nucleus itself and what happens...1736false12fullhttps://www.spreaker.com/episode/radphysics-e1-atomic-and-nuclear-structure--663462840aca962d-7d09-4df6-b48b-530ed05132b1Fri, 30 May 2025 23:44:28 +0000Abass ContehWelcome to RadOnc Smart Review, the podcast dedicated to sharpening your radiation oncology expertise. This is the very first episode of our Physics Series, E1: Atomic and Nuclear Structure. Today, we're going back to the absolute basics, the tiny...1051false11fullhttps://www.spreaker.com/episode/radbio-e38-oncogenic-pathways-ras-mapk-pi3k-akt-mtor-and-hif-1a--66345082d688a2a8-6778-4add-ba52-babc16d47054Fri, 30 May 2025 20:37:43 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 38: Oncogenic Pathways: RAS/MAPK, PI3K/AKT/mTOR, and HIF-1α. In our previous discussions, we've explored how cells sense and repair DNA damage, and how they make life-or-death decisions through...1701false238fullhttps://www.spreaker.com/episode/radbio-e37-g2-m-control-wee1-apoptosis-bcl-2-caspases--66345084584fb116-8e48-4a3d-8e5e-8e3a97c89ec4Fri, 30 May 2025 20:24:15 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 37: G2/M Control (Wee1) & Apoptosis (Bcl-2/Caspases). In our previous episode, we explored the intricate mechanisms of G1/S checkpoint control, highlighting the roles of p53, p21, and the...1805false237fullhttps://www.spreaker.com/episode/radbio-e36-cell-cycle-gate-keepers-p53-p21-rb-e2f--66344670d752615c-a253-4e08-8575-365bc641784dFri, 30 May 2025 19:39:13 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 36: Cell Cycle Gatekeepers: p53/p21 & Rb/E2F. In our previous episodes, we've delved into how cells sense and repair DNA damage. Today, we're going to focus on two critical molecular pathways...1217false236fullhttps://www.spreaker.com/episode/radbio-e35-dsb-repair-deep-dive-nhej-hrr-proteins--663376313bf43d5f-db77-4a59-8f2e-b216706ec451Fri, 30 May 2025 07:30:16 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 35: DSB Repair Deep Dive: NHEJ & HRR Proteins. In our last episode, we explored how cells sense DNA damage and initiate signaling cascades. Today, we're diving into the critical repair...1804false235fullhttps://www.spreaker.com/episode/radbio-e34-dna-damage-sensing-signaling-atm-atr-and-gh2ax--663343335da3cc05-b9f1-46e0-8d8d-41846e43b84cThu, 29 May 2025 22:25:29 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is Episode 34: DNA Damage Sensing & Signaling: ATM, ATR, and γH2AX. Today, we're diving deep into the cell's intricate emergency response system, the DNA Damage Response, or DDR. We'll explore how cells...1763false236fullhttps://www.spreaker.com/episode/radbio-e32-molecular-imaging-ct-pet--6633392626c57de4-afa9-4861-b2de-59e627a171a2Thu, 29 May 2025 22:22:59 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is RadBio Edition, Episode 32: Molecular Imaging (CT & PET) in RadOnc.In our previous episode, we explored the molecular tools that help us understand DNA damage, gene expression, and protein function....1385false232fullhttps://www.spreaker.com/episode/radbio-e33-cancer-immunology-radiation-synergy--66333935264ff5fe-da1b-4310-b654-00482ac87e5aThu, 29 May 2025 21:33:35 +0000Abass ContehWelcome back to Rad Onc Smart Review! Rad Bio Edition! Today we’re exploring a very hot topic in cancer therapy: the intersection of radiation and the immune system. This is Episode 33: Cancer Immunology & Radiation Synergy. For a long time,...1308false233fullhttps://www.spreaker.com/episode/radbio-e31-molecular-techniques-nucleic-acids-proteins--66333938597f922f-7e59-4840-9c42-e73981947f99Thu, 29 May 2025 21:32:07 +0000Abass ContehWelcome back to Rad Onc Smart Review! This is RadBio Edition, Episode 31: Molecular Techniques (Nucleic Acids & Proteins).In our journey through radiobiology, we've talked a lot about DNA damage, repair, cell cycle, and how radiation impacts these...2303false231fullhttps://www.spreaker.com/episode/radbio-e30-radiation-protection-limits-units-part-2--663339271ee13217-9613-4f96-af3a-d1b46c19816cThu, 29 May 2025 21:30:21 +0000Abass ContehWelcome back to Rad Onc Smart Review! Rad Bio Edition!This is Episode 30: Radiation Protection Limits & Units (Part 2). In our last episode, we established the fundamental principles of radiation protection, differentiating between stochastic and...1525false230fullhttps://www.spreaker.com/episode/radbio-e29-radiation-protection-fundamental-principles-and-basic-units--6633392974e1366c-8dd8-47d9-8efa-bfce06693510Thu, 29 May 2025 21:29:03 +0000Abass ContehThis is Episode 29: Radiation Protection - Fundamental Principles and Basic Units.In our previous episodes, we’ve explored the multifaceted ways radiation interacts with biological systems, from the molecular dance of DNA damage and repair to the...1330false229fullhttps://www.spreaker.com/episode/radbio-e28-radiation-effects-on-embryo-fetus--66333932e2f2b869-f23d-4ab8-8ac6-28de18e84b1fThu, 29 May 2025 21:27:41 +0000Abass ContehThis is Episode 28: Radiation Effects on Embryo & Fetus. In our previous episode, we explored the long-term stochastic risk of radiation-induced cancer. Today, we turn our attention to another critical area of radiation effects: the impact of in...1436false260fullhttps://www.spreaker.com/episode/radbio-e27-heritable-effects-of-radiation--663339349129bb33-4df2-4ba7-8fe4-cacebbe00e8bThu, 29 May 2025 21:26:13 +0000Abass ContehThis is Episode 27: Heritable Effects of Radiation.In our last episode, we explored how radiation can act as a carcinogen, looking at risk models and latency periods. Today, we shift our focus from somatic effects to the potential impact of radiation...1285false227fullhttps://www.spreaker.com/episode/radbio-e26-radiation-carcinogenesis-risk-models--66310351997d3476-9812-4f07-a853-8b9904c2e8f9Wed, 28 May 2025 09:01:27 +0000Abass ContehIn previous episodes, we've focused heavily on how radiation kills cancer cells and how normal tissues respond to therapeutic doses. Today, we shift our focus to a critical late effect of radiation exposure: the induction of cancer itself. Radiation,...1927false226fullhttps://www.spreaker.com/episode/radbio-e25-radioprotectors-hyperthermia--66310350ebbe4c07-3a5d-4be7-a15d-0cead03d5ee4Wed, 28 May 2025 08:59:59 +0000Abass ContehThis is Episode 25: Radioprotectors & Hyperthermia.In our previous discussions, we've explored ways to make tumor cells more vulnerable to radiation, particularly focusing on the challenge of hypoxia. Today, we're flipping the script slightly and...1460false225fullhttps://www.spreaker.com/episode/radbio-e24-radiosensitizers-bioreductive-drugs--66310348561493e7-dce5-40d6-a5f6-f4896f67d08cWed, 28 May 2025 08:58:45 +0000Abass ContehIn our previous discussions, we've established that factors like tumor hypoxia can significantly limit the effectiveness of radiation therapy. Today, we're diving into strategies designed to overcome this and other forms of radioresistance. We'll...1118false224fullhttps://www.spreaker.com/episode/radbio-e23-immunotherapy-radiation--663103520f22fc62-f63c-4a52-b06c-0356da068aa1Wed, 28 May 2025 08:57:03 +0000Abass ContehFor a long time, radiation therapy was primarily understood through its direct cytotoxic effects on tumor cells. But increasingly, we're recognizing that radiation is not just a local ablative tool; it's also a potent modulator of the tumor...1807false223fullhttps://www.spreaker.com/episode/radbio-e22b-chemo-rt-synergy-targeted-agents--66310349f04d6a66-ea0f-4ef3-aaf9-88f270883f8bWed, 28 May 2025 08:55:34 +0000Abass ContehIn our last episode, we laid out the broad principles of combining chemotherapy with radiation and surveyed the major classes of traditional cytotoxic drugs. Today, we're taking a closer look at the "why" and "how" of these combinations. We'll explore...1310false222fullhttps://www.spreaker.com/episode/radbio-e22a-chemo-rt-principles-drug-classes--662131908718cc82-a205-4b9f-bce1-afcd6193ab79Thu, 22 May 2025 21:35:14 +0000Abass ContehThis is Episode 22, Part A: Chemo+RT - Principles & Drug Classes.For decades, radiation therapy has been a cornerstone of cancer treatment, offering potent local control. But as we know, cancer can be a systemic disease, and sometimes radiation...1173false222fullhttps://www.spreaker.com/episode/radbio-e21b-advanced-modalities-imrt-flash--6621317409f8180d-7e95-4763-9fdc-968f6e30fc75Thu, 22 May 2025 21:33:53 +0000Abass ContehThis is Episode 21, Part B: Advanced Modalities - IMRT & FLASH.In our previous episode, we explored the exciting world of particle therapy, looking at how protons and heavy ions like carbon aim to improve treatment by precisely targeting tumors....1555false221fullhttps://www.spreaker.com/episode/radbio-e21a-advanced-modalities-particle-therapy--662086758c0949fa-c28d-48d2-9d2a-6776f8ef4257Thu, 22 May 2025 18:17:23 +0000Abass ContehThis is Episode 21, Part A: Advanced Modalities - Particle Therapy.In our previous episodes, we've explored the radiobiology of conventional photon therapy, including fractionation and dose rate effects, and we've touched on brachytherapy. Today,...1016false221fullhttps://www.spreaker.com/episode/physics-episode-p20-brachytherapy-radiobiology--66198521db3d8e30-8da4-4845-b20e-73cda74c7d2fThu, 22 May 2025 06:41:54 +0000Abass ContehWelcome back to Rad Onc Smart Review, Radiation Biology edition is Episode 20: Brachytherapy Radiobiology. In our previous discussions, we've explored the principles of fractionation, primarily in the context of external beam radiotherapy, where doses...1316false220fullhttps://www.spreaker.com/episode/radbio-e19-altered-fractionation-hyperfractionation-accelerated-radiotherapy-and-chart--66198513a7e8cf4a-68c4-4171-b933-41db2bc2013aThu, 22 May 2025 06:35:33 +0000Abass ContehThis is Episode 19: Altered Fractionation - Hyperfractionation, Accelerated Radiotherapy, and CHART.In our previous episode, we mastered the Linear-Quadratic model and the concept of Biological Effective Dose, tools that allow us to compare different...1411false219fullhttps://www.spreaker.com/episode/radbio-e18c-fractionation-the-lq-model-bed-and-isoeffect-curves--661985222251c623-f8ef-46ee-bd0b-471c924c3cefThu, 22 May 2025 06:31:20 +0000Abass ContehThis is Episode 18, Part C: Fractionation - The LQ Model, BED, and Isoeffect Curves.In our previous discussions on fractionation, we’ve explored the "4 R's" and the impact of dose rate. These concepts help explain why fractionated radiotherapy works....1301false218fullhttps://www.spreaker.com/episode/radbio-e18b-fractionation-dose-rate-effects--66197991d7190ce4-8630-4826-ad3d-f0338c11988fThu, 22 May 2025 05:39:02 +0000Abass ContehThis is Episode 18, Part B: Fractionation - Dose Rate Effects.In our last episode, we laid the groundwork by exploring the "Four Rs of Radiobiology" – Repair, Reassortment, Repopulation, and Reoxygenation – which explain the benefits of delivering...962false218fullhttps://www.spreaker.com/episode/radbio-e18a-fractionation-the-four-rs-of-radiobiology--66198050fffeb04c-3aab-4a19-b027-cb1025fd4bddThu, 22 May 2025 05:37:53 +0000Abass ContehThis is Episode 18, Part A: Fractionation - The Four Rs of Radiobiology.In our last episode, we discussed the therapeutic ratio and the ongoing quest to predict how tumors and normal tissues will respond to radiation. One of the oldest and still most...1096false218fullhttps://www.spreaker.com/episode/physics-episode-e17-therapeutic-ratio-predictive-assays--6619805806e06e9e-fa42-4106-9233-ad83618710ebThu, 22 May 2025 05:32:40 +0000Abass ContehThis is Episode 17: Therapeutic Ratio & Predictive Assays. In our previous episodes, we've explored how radiation interacts with cells and tissues, the different types of damage it causes, and how cells attempt to repair that damage. We've also...1831false217fullhttps://www.spreaker.com/episode/radbio-e16-normal-tissue-mechanisms-functional-subunits-cytokines-and-fibrosis--6619649972d73f4f-f888-4642-98c9-c5dbfe82f13dThu, 22 May 2025 03:11:53 +0000Abass ContehThis is Episode 16: Normal Tissue Mechanisms: Functional Subunits, Cytokines, and Fibrosis.In our previous episodes covering normal tissue effects, we've seen how different organs respond to radiation over various timescales, manifesting as either...1469false216fullhttps://www.spreaker.com/episode/radbio-e15d-normal-tissues-late-effects-on-gonads-and-bone--66196496105a52a2-f3d3-48f3-bc74-bcfc61713553Thu, 22 May 2025 02:59:35 +0000Abass ContehThis is Episode 15, Part D: Normal Tissues - Late Effects on Gonads and Bone.In our previous episodes, we've explored the late detrimental effects of radiation on critical organs like the central nervous system, lungs, heart, and kidneys. Today, we...1078false215fullhttps://www.spreaker.com/episode/radbio-e15c-normal-tissues-late-effects-heart-kidney-and-lens--66196498aa0b664d-8687-4376-81da-fbe65d7c9c2aThu, 22 May 2025 02:41:45 +0000Abass ContehThis is Episode 15, Part C: Normal Tissues - Late Effects (Heart, Kidney, and Lens).In our previous episode, we discussed the late effects of radiation on the central nervous system and the lungs. Today, we continue our exploration of late normal...1456false215fullhttps://www.spreaker.com/episode/radbio-e15b-normal-tissues-late-effects-focusing-on-the-central-nervous-system-and-lungs--66196497fc167386-16e9-4aa6-87f9-c209bcd594c4Thu, 22 May 2025 02:31:58 +0000Abass ContehIn our previous episode, we explored the acute, or early, effects of radiation on rapidly dividing normal tissues like the skin, gut, and bone marrow. These effects, while often distressing, are typically transient and heal. Today, we shift our...1406false215fullhttps://www.spreaker.com/episode/radbio-e15a-normal-tissues-early-effects-on-skin-gut-and-bone-marrow--66191676013c4583-9597-4990-9fd2-d52119ba3f1eWed, 21 May 2025 19:25:14 +0000Abass ContehIn our last episode, we discussed the dramatic and often devastating consequences of Total Body Irradiation, focusing on the acute radiation syndromes. Today, we're narrowing our focus to the specific early, or acute, effects of radiation on some of...1253false215fullhttps://www.spreaker.com/episode/radbio-e14-total-body-irradiation-tbi-syndromes--66191667cb710b12-629d-48b4-bc62-ace3003c8875Wed, 21 May 2025 19:20:16 +0000Abass ContehThis is Episode 14, Total Body Irradiation (TBI) Syndromes. Today, we're shifting our focus from the cellular level to the effects of radiation on the whole organism, specifically when the entire body is exposed to a significant dose of radiation....1007false214fullhttps://www.spreaker.com/episode/radbio-e13d-cancer-biology-hallmarks-telomeres--66162643e32e8a65-a312-46d9-8017-b633e98808e4Tue, 20 May 2025 01:13:43 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast that simplifies the science behind cancer treatment. This is Episode 13 Part D, Cancer Biology - Hallmarks & Telomeres. In our previous cancer biology segments, we've explored the individual...988false213fullhttps://www.spreaker.com/episode/radbio-e13c-cancer-biology-signaling-egfr-ras-pi3k-myc-and-nf-kb--66162645ce304ff2-5460-4129-9352-1ea645dd3036Tue, 20 May 2025 01:12:28 +0000Abass ContehThis is Episode 13 Part C, Cancer Biology - Signaling: EGFR, Ras, PI3K, Myc, and NF-κB.In our previous episodes on cancer biology, we've explored oncogenes – the cellular accelerators – and tumor suppressor genes – the cellular brakes. Today, we're...1407false213fullhttps://www.spreaker.com/episode/radbio-e13b-repair-over-time-sld-pld-dose-rate-tts--66162644530ff3e5-2df8-41f9-b859-225113c56209Tue, 20 May 2025 01:10:34 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast dedicated to helping you master the core concepts of radiation oncology and radiobiology. This is Episode 13 Part B, Cancer Biology - Tumor Suppressor Genes .In our previous episode, we delved into the...1481false213fullhttps://www.spreaker.com/episode/radbio-e13a-cancer-biology-oncogenes--6614897432428c91-e779-467c-8fa5-850b136e59b3Mon, 19 May 2025 10:09:19 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast dedicated to helping you master the core concepts of radiation oncology and radiobiology. This is Episode 13 Part A, Cancer Biology - Oncogenes.In our previous episodes, we've explored the intricacies...1228false213fullhttps://www.spreaker.com/episode/radbio-e12b-tumor-kinetics-tpot-gf-cell-loss--6614897123b5180a-c64a-40b9-85fb-41f13ea1181fMon, 19 May 2025 10:07:39 +0000Abass ContehWelcome back to Rad Onc Smart Review, your go-to podcast for mastering the core concepts of radiation oncology and radiobiology. This is Episode 12 Part B, Tumor Kinetics - Tpot, GF & Cell Loss. In our previous episode, P12a, we laid the...1009false212fullhttps://www.spreaker.com/episode/radbio-e12a-cell-cycle-kinetics-phases-measurement--661489756e7ca6da-0047-4dd3-b077-837c41da8aefMon, 19 May 2025 10:05:23 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast that helps you master the core concepts of radiation oncology and radiobiology. This is Episode 12 Part A, Cell Cycle Kinetics - Phases & Measurement. In our previous episodes, we've explored how...1283false212fullhttps://www.spreaker.com/episode/radbio-e11b-tumor-microenvironment-angiogenesis-hif-1--6614897226faf75e-11b7-4a8f-a101-e2163427cf9fMon, 19 May 2025 10:03:00 +0000Abass ContehThis is Episode 11 Part B, Tumor Microenvironment - Angiogenesis & HIF-1. In our last episode, we explored the critical issue of tumor hypoxia and how reoxygenation plays a role during fractionated radiotherapy. Today, we're going to build on that...1089false211fullhttps://www.spreaker.com/episode/radbio-e11a-tumor-microenvironment-hypoxia-reoxygenation--66148976307e0744-0578-49b5-81e5-58a9c9f47248Mon, 19 May 2025 09:41:44 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast that helps you master the core concepts of radiation oncology and radiobiology. This is Episode 11 part A, Tumor Microenvironment - Hypoxia & Reoxygenation. Today, we're diving deep into the tumor...1397false211fullhttps://www.spreaker.com/episode/radbio-e10-tumor-assays-growth-delay-tcd50--66141924ea25f529-049d-48a5-bd42-32c7578a403aSun, 18 May 2025 19:14:47 +0000Abass ContehWelcome back to Rad Onc Smart Review.This is Episode 10, Tumor Assays: Growth Delay & TCD50.In our previous episodes, we delved into the cellular responses to radiation, looking at survival curves and models like the LQ model, often derived from...1196false210fullhttps://www.spreaker.com/episode/radbio-e9-repair-over-time-sld-pld-dose-rate-tts--6609020865175135-6c1a-4a68-ab69-124caebb0ec8Wed, 14 May 2025 19:16:14 +0000Abass ContehWelcome back to Rad Onc Smart Review. This is Episode 9, Repair, SLD, PLD & Dose Rate Effects. Today, we're diving deep into how cells respond to radiation damage, focusing on the crucial concepts of sublethal and potentially lethal damage repair,...1098false29fullhttps://www.spreaker.com/episode/radbio-e8-the-oxygen-effect-and-oxygen-enhancement-ratio--66080696b403c8f8-90c4-43fe-9195-7620a058c87dWed, 14 May 2025 04:03:57 +0000Abass ContehThis is Episode 8, The Oxygen Effect & OER.In our last episode, we explored how Linear Energy Transfer (LET) influences the Relative Biological Effectiveness (RBE) of different radiation types, explaining why equal absorbed doses don't always lead...936false28fullhttps://www.spreaker.com/episode/radbio-e7-let-s-talk-r-b-e--660224107bbefea7-8160-44a4-86c6-5198cf042360Fri, 09 May 2025 20:26:46 +0000Abass ContehThis is Episode 7, LET's Talk RBE.In our last episode, we saw how mathematical models like the Linear-Quadratic model describe cell survival curves. But a key point emerged: equal doses of different types of radiation don't necessarily produce equal...1271false27fullhttps://www.spreaker.com/episode/radbio-e6-modeling-survival-target-theory-and-l-q--65982138ad7c70e3-f9e4-4b07-a868-248d5b0c4383Wed, 07 May 2025 18:55:22 +0000Abass ContehThis is Episode 6, Modeling Survival: Target Theory and L Q.In our last episode, we looked at how radiobiologists actually measure cell survival using clonogenic assays. These experiments generate dose-response data, typically plotted as cell survival...1235false26fullhttps://www.spreaker.com/episode/radbio-e5-measuring-survival-clonogenic-assays--6598212947a4ab35-55d0-4551-9123-e96608182676Wed, 07 May 2025 18:47:44 +0000Abass ContehThis is Episode 5, Measuring Survival: Clonogenic Assays.In our last episode, we explored the different ways cells can die after radiation – apoptosis, necrosis, mitotic catastrophe, and others. But in radiation oncology, the ultimate goal isn't just...1125false25fullhttps://www.spreaker.com/episode/radbio-e4-dna-repair-mechanisms-of-cell-death-response--659805004b3bb4d7-99ea-43b1-a9a0-03b6e44eb16aWed, 07 May 2025 18:21:55 +0000Abass ContehWelcome back to Rad Onc Smart Review. This is Episode 4, Mechanisms of Cell Death & Response.Last time, we explored how radiation can cause major structural damage to chromosomes. Today, we're diving into the consequences of that damage, looking...1236false24fullhttps://www.spreaker.com/episode/radbio-e3-dna-repair-chromosome-damage-and-repair-syndromes--6580163332a89201-3590-4a66-9632-c5c6d7b391a2Wed, 30 Apr 2025 03:32:32 +0000Abass ContehIn our last episodes, we drilled down into how cells repair specific DNA lesions, like base damage, single-strand breaks, and those critical double-strand breaks via NHEJ and HR. Today, we're zooming out to look at the bigger picture: what happens...1663false23fullhttps://www.spreaker.com/episode/radbio-e2c-homologous-recombination--6580110041f650e6-0c9a-44fc-9009-910606bd03c4Wed, 30 Apr 2025 02:36:13 +0000Abass ContehIn our previous episode, we discussed how cells handle single strand breaks and how they perform a quick but potentially error filled patch up of double strand breaks using Non-Homologous End Joining, or NHE J. Today, we're diving into the cell's high...1140false22fullhttps://www.spreaker.com/episode/physics-episode-17-d-lungs-seeds-and-safety-shields--65798874e0bffd53-dc68-43ec-8465-d08db7f02f01Tue, 29 Apr 2025 22:02:59 +0000Abass ContehThis is our final episode focused purely on calculations! We've journeyed from basic decay to complex Monitor Unit calculations. Today, we hit the advanced scenarios: What happens when the beam hits lung or bone? How do we compare radically different...1399false117fullhttps://www.spreaker.com/episode/physics-episode-p17c-dose-divers-and-electron-escapades--6577803866711eef-3994-4aad-aad6-183ef3249924Mon, 28 Apr 2025 08:20:01 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – Calculation Toolkit Episode 17C: Dose Divers and Electron Escapades. Last time, we calibrated our detectors and nailed Monitor Unit calculations for standard setups. Now, we follow the dose after it...974false117fullhttps://www.spreaker.com/episode/physics-episode-p17b-dosimetry-detectives-and-chamber-charades--65778039ed2543de-2abd-44a9-afd5-2786caa95c57Mon, 28 Apr 2025 08:10:44 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – Episode 17 part B: Dosimetry Detectives and Chamber Charades. Last time, we tackled the ticking clocks of decay and permanent implants. Today, we put on our detective hats to investigate how we...931false117fullhttps://www.spreaker.com/episode/physics-episode-p17a-calculations-1-half-lives-and-seed-sleuths--6577804116c56509-64e4-416f-a8c0-b52103563fd1Mon, 28 Apr 2025 08:01:43 +0000Abass ContehWelcome back to Radiation Oncology Smart Review – the targeted prep for your radiation oncology boards! I’m your guide, diving deep into the calculations that matter. This is Episode 17a of our Calculation Toolkit series, titled Radiation Oncology...931false117fullhttps://www.spreaker.com/episode/radbio-e2b-dna-repair-single-strand-breaks-nhej--65758244e974dc7e-a962-453f-99e3-80b6ca979977Sun, 27 Apr 2025 03:57:42 +0000Abass ContehThis is Episode 2b, DNA Repair: Single-Strand Breaks& NHEJ.Last time, we delved into Base Excision Repair andNucleotide Excision Repair, the cell's tools for fixing damaged bases and bulkylesions. But ionizing radiation does more than just damage...1547false22fullhttps://www.spreaker.com/episode/radbio-e2a-dna-repair-base-nucleotide-excision--65733527bb26eabb-7b90-4985-94d5-465e11f33901Fri, 25 Apr 2025 23:35:59 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast that helps you master radiation oncology concepts for your boards and beyond.This is Episode 2a, DNA Repair: Base & Nucleotide Excision.In our last episode, we saw how radiation causes a spectrum...1289false22fullhttps://www.spreaker.com/episode/radbio-e1-radiation-interaction-damage-basics--65731923fa8bbcb3-57cd-4fc7-a040-a6828944b9daFri, 25 Apr 2025 22:18:56 +0000Abass ContehWelcome back to Rad Onc Smart Review, the podcast that helps you master radiation oncology concepts for your boards and beyond.This is Episode 1, Radiation Interaction & Damage Basics.Today, we’ll explore how ionizing radiation initially interacts...1847false21fullhttps://www.spreaker.com/episode/physics-episode-p16c-pet-ultrasound-physics-for-radonc--65575404e51b07d6-d076-4bba-8c19-216623d7dd03Sun, 06 Apr 2025 21:34:22 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series for our concluding episode! In P16b, we explored the crucial planning modalities of CT and MRI. Today, in Episode P16c: PET & Ultrasound Physics for RadOnc, we round out our imaging tour by...1618false116fullhttps://www.spreaker.com/episode/physics-episode-p16b-ct-mri-physics-for-radonc--65575430525ea3e3-e395-49c8-8a85-c334c7a88846Sun, 06 Apr 2025 20:34:21 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P16a, we covered the crucial principles of radiation protection and the regulations governing our field. Now, in Episode P16b: CT & MRI Physics for RadOnc, we dive into the physics behind...1278false116fullhttps://www.spreaker.com/episode/physics-episode-p16a-radiation-protection-regulations--65575461bf626632-1de7-438d-8c12-1a53ad0d742bSun, 06 Apr 2025 20:33:10 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've explored how radiation is produced, how it interacts, how we measure it, plan treatments, and ensure quality. Now, we circle back to a fundamental responsibility: radiation safety. In...1578false116fullhttps://www.spreaker.com/episode/physics-episode-p15c-brachytherapy-qa-safety-regulations--65575431d5d2970d-15d7-467b-976e-c5a48be89cf7Sun, 06 Apr 2025 20:23:31 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P15a, we covered brachytherapy sources and TG-43 dose calculations. In P15b, we looked at clinical applications and planning systems. Now, in our final brachytherapy episode, P15c:...1178false115fullhttps://www.spreaker.com/episode/physics-episode-p15b-brachytherapy-applications-systems-planning-concepts--65575444ee16ae09-06a6-4de6-8f6d-d51a793b94bcSun, 06 Apr 2025 20:22:51 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P15a, we laid the groundwork for brachytherapy, focusing on the radioactive sources, how their strength is quantified using Air Kerma Strength (SK), and the details of the TG-43 dose...1619false115fullhttps://www.spreaker.com/episode/physics-episode-p15a-brachytherapy-physics-sources-strength-dose-calculation--655754086eb165be-5119-4e34-8263-396fd8c32734Sun, 06 Apr 2025 20:21:49 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've thoroughly covered external beam therapy. Now, we're shifting gears dramatically to explore treatments where the radiation source is placed inside or very close to the target. In Episode...1565false115fullhttps://www.spreaker.com/episode/physics-episode-p14b-proton-therapy-physics-planning--65575470b74e6dd4-efed-4e6b-a428-3c64381d0556Sun, 06 Apr 2025 20:20:57 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P14a, we explored the world of electron beams. Now, in Episode P14b: Proton Therapy Physics & Planning, we turn to the heavyweights: protons. Protons offer a unique dose deposition...1751false114fullhttps://www.spreaker.com/episode/physics-episode-p14a-electron-beam-physics-planning--655754696c652335-ccd1-4600-b505-e2911bfacc83Sun, 06 Apr 2025 20:19:19 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! After exploring advanced photon techniques like IMRT, VMAT, and SRS/SBRT, we're now switching particle types. In Episode P14a: Electron Beam Physics & Planning, we focus entirely on the...1534false114fullhttps://www.spreaker.com/episode/episode-p13b-stereotactic-techniques-srs-sbrt-physics-delivery--655754392ecd0b67-019c-4d93-8e06-ab83a5b47bedSun, 06 Apr 2025 20:17:08 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P13a, we covered the principles of IMRT and VMAT for delivering conformal dose distributions. Today, in Episode P13b: Stereotactic Techniques, we push the boundaries of precision even further....1263false113fullhttps://www.spreaker.com/episode/physics-episode-p13a-intensity-modulated-therapy-imrt-vmat-principles-qa--65575397039ea71e-c6c7-4bb1-bc2b-d124025820ccSun, 06 Apr 2025 20:10:52 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P12b, we defined the crucial ICRU target volumes (GTV, CTV, PTV). Now, how do we deliver dose that conforms tightly to those volumes, especially when they're complex shapes wrapped around...1763false113fullhttps://www.spreaker.com/episode/physics-episode-p12b-treatment-planning-volumes-concepts--65575413910074fa-3534-4d37-bdf4-1b1657fef5b5Sun, 06 Apr 2025 18:27:45 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P12a, we mastered the formulas for calculating Monitor Units to deliver a specific dose to a point. But radiation therapy treats volumes. How do we define these volumes precisely, accounting...1317false112fullhttps://www.spreaker.com/episode/physics-episode-p12a-mu-calculations-ssd-sad-formulas--655754419ba34146-aa8b-4db1-a4c2-eb59e2703f7fSun, 06 Apr 2025 18:26:36 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! We've gathered all the ingredients: Calibrated Output (CAL), Output Factors (Sc,p), Beam Modifiers (WF, TF), and Patient Attenuation Factors (PDD, TMR). Now, in Episode P12a: MU Calculations (SSD...1226false112fullhttps://www.spreaker.com/episode/physics-episode-p11-mu-calculation-components--655754429349dd58-1301-4a12-a34b-567713633121Sun, 06 Apr 2025 18:25:40 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In Episode P10, we defined the key descriptors of dose distribution – PDD for SSD setups and TMR for SAD setups – which tell us how dose varies with depth, energy, and field size relative to a...1209false111fullhttps://www.spreaker.com/episode/physics-episode-p10-ebrt-dose-descriptors--65575445bd2c8e27-17ae-412a-b8be-d949dab46c76Sun, 06 Apr 2025 17:36:16 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P9, we mastered the art of calibration using TG-51, linking machine output (MU) to absolute dose under reference conditions. But patients aren't water phantoms treated at 10 cm depth with a...1467false110fullhttps://www.spreaker.com/episode/physics-episode-p9-tg-51-calibration-essentials--6557542070e5ee0d-fe0a-41b2-b2c9-5e3e3365d9e4Sun, 06 Apr 2025 17:22:53 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P8, we stressed the importance of Quality Assurance – making sure our LINACs work correctly. But QA relies on having an accurate baseline measurement of the machine's output. How do we...1345false19fullhttps://www.spreaker.com/episode/physics-episode-p8b-quality-assurance-qa-for-linacs-simulators--6557542679fca5b1-c0c0-43fd-8524-5a2d16e8a775Sun, 06 Apr 2025 17:14:21 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P8a, we discussed Beam Quality – how penetrating our radiation beams are. Now, in Episode P8b: Quality Assurance (QA) for Linacs & Simulators, we tackle the absolutely essential processes...1335false18fullhttps://www.spreaker.com/episode/physics-episode-p8a-to-the-beam-quality-characteristics--6557544667164870-31d3-4a12-a961-4c816c084886Sun, 06 Apr 2025 17:11:30 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! After diving deep into dosimetry detectors and concepts in P7a and P7b, we now turn our focus in Episode P8a to the Beam Quality & Characteristics. How do we objectively describe the...1422false18fullhttps://www.spreaker.com/episode/physics-episode-p7b-bragg-gray-theory-the-dosimetry-toolkit--65575449fe52688a-98a3-465f-863e-bcba38e44540Sun, 06 Apr 2025 17:09:13 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P7a, we established the concept of Exposure, detailed the ionization chamber, and learned how the f-factor converts exposure-in-air to dose-in-medium. But how can we be sure that measuring...1934false17fullhttps://www.spreaker.com/episode/physics-episode-p7a-measuring-dose-exposure-ion-chambers-the-f-factor--6557547125fedf2d-a0a5-4665-90d8-27f0e16f082dSun, 06 Apr 2025 17:07:45 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P6, we saw how photons interact – PE, Compton, Pair Production. Now we need to quantify the result: dose. In Episode P7a: Measuring Dose - Exposure, Ion Chambers & The f-factor, we'll...1467false17fullhttps://www.spreaker.com/episode/physics-episode-p6-photon-interactions-basic-dose-concepts--655754078fa61a4e-8732-4d8b-b96f-65e346357441Sun, 06 Apr 2025 17:05:21 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P5, we explored the powerful machines, especially LINACs, that generate high-energy photon (X-ray) beams. Now that we have these beams, what happens when they actually hit the patient? In...1530false16fullhttps://www.spreaker.com/episode/physics-episode-p5-high-energy-treatment-machines--65575406305c91a7-daa8-4ec4-b915-8287839dfa7bSun, 06 Apr 2025 07:42:35 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! Last episode, P4, we learned how kV X-rays are produced in tubes. Today, we're powering up significantly in Episode P5: High Energy Treatment Machines. We'll explore the historical Cobalt-60...1692false15fullhttps://www.spreaker.com/episode/physics-episode-p4-kv-x-ray-production--655754100247fa74-ab0d-48a4-9f8e-4fd6f0f2c6f9Sun, 06 Apr 2025 07:40:14 +0000Abass ContehWelcome back to RadOnc Smart Review, Physics Series! In P3, we saw how charged particles like electrons lose energy interacting with matter. Today, in Episode P4: kV X-ray Production, we harness those interactions! We'll focus specifically on how we...1399false14fullhttps://www.spreaker.com/episode/physics-episode-p3-particulate-interactions--655754721b4aaa03-a9aa-45a9-86d1-2dbfa4a64bbfSun, 06 Apr 2025 07:37:20 +0000Abass ContehWelcome back to the RadOnc Smart Review Physics Series! In P2, we explored radioactive decay, where unstable nuclei emit particles like alphas and betas. Now, in Episode P3: Particulate Interactions, we'll follow those particles – and others like...1428false13fullhttps://www.spreaker.com/episode/physics-episode-p2-radioactive-decay--65575476c3f43653-1582-41e3-be41-964a865812a8Sun, 06 Apr 2025 07:35:34 +0000Abass ContehWelcome back to RadOnc Smart Review, Physics Series! Last time, in P1, we looked at the atom's structure and what happens when electrons get shuffled around. Today, in Episode P2: Radioactive Decay, we're focusing on the nucleus itself and what...1631false12fullhttps://www.spreaker.com/episode/episode-p1-atomic-nuclear-structure--6557547732820eb9-eb9e-477d-be0e-f1e1f2040256Sun, 06 Apr 2025 07:29:20 +0000Abass ContehWelcome to RadOnc Smart Review, the podcast dedicated to sharpening your radiation oncology expertise. This is the very first episode of our Physics Series, P1: Atomic and Nuclear Structure. Today, we're going back to the absolute basics, the tiny...1690false11full